Skip Navigation Bar
National Intitutes of Health
This finding aids platform will be replaced in Fall 2022. Please explore the new platform Beta soft release by visiting https://archivesspace.nlm.nih.gov


National Library of Medicine

Finding Aid to the Robert M. Chanock Papers, 1933-2008 (bulk 1950-2008)

History of Medicine Division
Processed by Jim Labosier
Encoded by Jim Labosier
Processing completed July 2018


Summary Information
Title: Robert M. Chanock Papers
Creator: Chanock, Robert M.
Dates: 1933-2008 (bulk 1950-2008)
Extent: 87.5 linear feet (70 boxes)
Abstract:
Correspondence, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's career studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses.

Call number: MS C 628
Language: Collection materials primarily in English
Location: Materials stored onsite. History of Medicine Division. National Library of Medicine

Access Restrictions:

Collection is restricted. Portions of the collection are restricted according to HMD's Access to Health Information of Individuals policy. Contact the Reference Staff for information regarding access. For access to the policy and application form, please visit https://www.nlm.nih.gov/hmd/manuscripts/phi.pdf.

Copyright and Re-use Information

Donor's copyrights were transferred to the public domain. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.

Privacy Information

Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.

Preferred Citation:

Chanock, Robert M. Robert M. Chanock Papers. 1933-2008 (bulk 1950-2008). Located in: Archives and Modern Manuscripts Collection, History of Medicine Division, National Library of Medicine, Bethesda, MD; MS C 628.

Processing Information

The Robert Chanock Papers were rehoused from their original containers into archival containers after initial receipt from the donor. In the course of final processing several categories of material were weeded from the original accession and discarded by the processing archivist: books and reprints about viral research not authored by Chanock (books also reviewed for retention by Rare Books staff); personally identifiable information in the form of personnel records, performance reviews, and letters of recommendation relating to employees supervised by Chanock; files relating to Chanock's personal finances. Archivists augmented the original collection by conducting an Archive-It web crawl of selected websites.

Provenance:

Gift, Stephen Chanock, February 15, 2011, Acc. 2011-009; Transfer, Jeffrey Cohen/NIAID, June 17, 2011, Acc. 2011-024.


101574531Finding Aid to the Robert M. Chanock Papers, 1933-2008 (bulk 1950-2008)Archives and Modern Manuscripts Program, History of Medicine Division1.0History of Medicine Division, National Library of Medicine.
8600 Rockville Pike
Bethesda, Maryland, 20894
USA
Phone: (301) 402-8878 (Reference Desk)
Fax: (301) 402-0872
Email: hmdref@nlm.nih.gov
Machine-readable finding aid encoded by Jim LabosierFinding aid is written in English

National Library of Medicine

Finding Aid to the Robert M. Chanock Papers, 1933-2008 (bulk 1950-2008)

History of Medicine Division
Processed by Jim Labosier
Encoded by Jim Labosier
Processing completed July 2018

Descriptive Summary

Chanock, Robert M.Robert M. Chanock Papers Dates: 1933-2008 (bulk 1950-2008)87.5 linear feet (70 boxes)MS C 628Materials stored onsite. History of Medicine Division. National Library of Medicine Collection materials primarily in EnglishAbstract:Correspondence, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's career studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses.Provenance:

Gift, Stephen Chanock, February 15, 2011, Acc. 2011-009; Transfer, Jeffrey Cohen/NIAID, June 17, 2011, Acc. 2011-024.

Access Restrictions:

Collection is restricted. Portions of the collection are restricted according to HMD's Access to Health Information of Individuals policy. Contact the Reference Staff for information regarding access. For access to the policy and application form, please visit https://www.nlm.nih.gov/hmd/manuscripts/phi.pdf.

Copyright and Re-use Information

Donor's copyrights were transferred to the public domain. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.

Privacy Information

Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.

Preferred Citation:

Chanock, Robert M. Robert M. Chanock Papers. 1933-2008 (bulk 1950-2008). Located in: Archives and Modern Manuscripts Collection, History of Medicine Division, National Library of Medicine, Bethesda, MD; MS C 628.

Processing Information

The Robert Chanock Papers were rehoused from their original containers into archival containers after initial receipt from the donor. In the course of final processing several categories of material were weeded from the original accession and discarded by the processing archivist: books and reprints about viral research not authored by Chanock (books also reviewed for retention by Rare Books staff); personally identifiable information in the form of personnel records, performance reviews, and letters of recommendation relating to employees supervised by Chanock; files relating to Chanock's personal finances. Archivists augmented the original collection by conducting an Archive-It web crawl of selected websites.

Biographical Note

Robert M. Chanock (1924-2010) was an influential pediatrician and virologist. He served as head of the National Institute of Allergy and Infectious Disease's (NIAID) Laboratory of Infectious Diseases (LID) from 1968 to 2001. He is best known for making major contributions to the prevention and treatment of childhood respiratory infections. Chanock was an internationally renowned virologist who identified a baffling pathogen that infects the majority of infants and is the most common cause of life-threatening pneumonia in premature babies; the first to identify and characterize this pathogen, which he called human respiratory syncytial virus, or RSV. During his six-decade career at NIAID Chanock performed wide-ranging and groundbreaking research on a number of stubborn and dangerous diseases, particularly those affecting children and babies. He was equally admired by colleagues for his ability to foster a dynamic and creative environment in which other scientists also thrived. Members of his lab group identified Norovirus (Norwalk virus), which causes intestinal flu, and developed the first nasal spray flu vaccine. He led research into adenovirus, hepatitis A, rotavirus, West Nile virus, and dengue fever. His team developed vaccines for Hepatitis A, rotavirus, and West Nile virus as well as the first nasal spray flu vaccine. Chanock holds several patents for these inventions and many others.

Chanock was born and grew up in Chicago. Drafted into the Army in 1943 and given a choice to deploy overseas or go to medical school, he chose school and was accepted into the University of Chicago undegraduate school and its School of Medicine, receiving degrees in 1945 and 1947. After interning at Highland Hospital in Oakland, Ca., he returned to Chicago for training in pediatrics. In 1950 while on a fellowship at Cincinnati Children's Hospital, he began working with his mentor and professional inspiration, Dr. Albert Sabin.

Chanock was drafted again in 1952 during the Korean War and was sent to Korea to deal with an outbreak of Japanese encephalitis, also known as Japanese B virus. Chanock never completed this work after suffering a burst appendix; instead he turned to researching infectious diseases while stationed in Tokyo for the remainder of his Korean War service. Upon his return to civilian life, Dr. Chanock studied little-understood viruses which commonly plagued infants. His research took him back to Cincinnati Children's Hospital and Johns Hopkins University before he joined NIAID at NIH. In 1957 he discovered the human respiratory syncytial virus (RSV), which causes respiratory infections in infants. This breakthrough was followed by the determination of four related agents, called para-influenza viruses.

In 1962 Dr. Chanock demonstrated that atypical or walking pneumonia was caused by the bacterium mycoplasma pneumoniae and that it could be cured with antibiotics. His lab developed vaccines to prevent adenovirus infection, Hepatitis A, and rotavirus, the most common cause of severe diarrhoea in infants and young children, and importantly the first nasal spray flu virus vaccine for use with children.

Dr. Chanock is considered an important and influential virologist. He became a member of the National Academy of Sciences in 1973 and is the recipient of the Robert Koch Prize, the Albert B. Sabin Gold Medal, the E. Mead Johnson Award, the Public Health Service’s Meritorious Service Medal, the Distinguished Service Medal, and the Gorgas Medal. Chanock died at age 86 on July 30, 2010.


Correspondence, lab notebooks, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's professional research career at NIAID's Laboratory of Infectious Disease studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses. Research strengths include a nearly comphrehnsive set of lab notebooks documenting the lab's work on Respiratory Syncytial Virus (RSV) and Paramyxoviridae infections and the business of collaborating with various pharmaceutical companies to produce vaccines.

Series 1, Personal and Biographical (1933-2008), includes correspondence (1950-1957) from research positions Dr. Chanock held before joining NIAID, at the University of Cincinnati and Johns Hopkins, and in the Army in Korea. Dr. Chanock's personal and family life are reflected in correspondence and congratulatory exchanges from colleagues (1933-2008) along with photographs (c.1950s-2005), oral history transcripts (2001-2003), and certificates and awards (1964-2008).

Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID) (1955-2008) contains incomplete sets of NIAID annual reports (1967-1983), LID annual reports (1966-1997), and LID Board of Scientific Counselor's Reviews (1978-2004). Correspondence (1955-2008) exists in varied orientations: a group arranged alphabetically by correspondent surname spans 1957 to 1979; chronological files are incomplete from 1968 to 1995 and are augmented by informally collected "chronological" files dated 1957-2008; there are also files, arranged alphabetically, by subject (1955-2007). Completing the series is a group of 35mm slide presentations (1961-2005), arranged chronologically, on LID research topics such as mycoplasma and respiratory syncytial virus.

Series 3, Research (1951-2008) is the largest portion of the collection and has many sections. Lab notebooks (1958-2000) are probably the most comprehensive and valuable part of this series. Arranged by surname of the LID researcher, they provide a day to day picture of research being conducted in the lab. The work of Dr. Chanock, Albert Kapikian, and Wallace P. Rowe are documented here, along with nine other researchers. A smaller set of lab notebooks designated by subject title, such as neuroaminidase, is arranged alphabetically. Research data, (1950-2008), is the least well described part of this series. Often these chronologically arranged folders bear brief titles, leaving only the material's date and context to aid in determining more specifically what studies they may pertain to. Cooperative Research and Development Agreements (CRADA) (1972-2003) with several pharmaceutical companies, notably Lederle and Wyeth, are arranged alphabetically by company name. Research contract reports range in date from 1952 to 1998. All of them after 1957 are contracts with NIAID. Most are arranged by contract number, the bulk of whose numbers are prefaced by "N01" or "PH". Proposals for research contracts which don't correspond to known contracts (1955-2001) are arranged chronologically. Investigational New Drugs (IND) reports (1963-2001) record results, in the form of supplements, of experimental drug testing by NIAID in collaboration with pharmaceutical companies. These are arranged by the Food and Drug Administration's assigned IND number. LID lab research reports (1960-2004) concern only documentation of studies undertaken in the NIAID lab without collaborators. These are arranged chronologically except in the few exceptions when contract numbers are evident.

Series 4, Patents (1966-2008) which Dr. Chanock co-invented, is arranged numerically by patent number. Related to each is material often in several folders documenting the patent submission and approval process, licensing to pharmaceutical companies, and applications for corresponding foreign patents.

Series 5, Writings/Reprints (1953-2007) contains an incomplete set of Dr. Chanock's scientific articles, which in their entirety total 653 (1953-2003). Smaller subsections of this series hold eight articles by Dr. Chanock which are not represented on his bibliography (1954-2007); drafts of articles not corresponding with his published work (c.1960s-c.2007); and untitled drafts and writing fragments (c.1955-c.2007). Reprints are arranged by number assigned in Dr. Chanock's bibliography. The other sections are chronological.

Series 6, Meetings (1954-2005) contains programs, proceedings, notes, and other related information collected by Dr. Chanock when he attended national and international health conferences focusing on virology. He regularly attended meetings held by the American Society for Clinical Investigation, World Health Organization, American Epidemiological Society, and American Society for Microbiology. The series is arranged chronologically.

Series 7, Lectures and Speeches (1951-2005) are arranged chronologically. While a number of the earlier speeches lack identification as to where or when they were delivered, most after 1970 were lectures given at conferences or on honorary occasions.

Series 8, Videocassettes (1985-1987) mostly cover two subjects: the February 12, 1985 Wallace P. Rowe Symposium, and the August 26, 1986 Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday.

Index Terms

These terms are indexed in the National Library of Medicine's online catalog LocatorPlus. Researchers wishing to find related materials should search the catalog using these terms.

    MeSH Subjects

    • Antibodies, Bacterial
    • Bacterial Vaccines
    • Immunotherapy
    • Paramyxoviridae Infections
    • Respiratory Syncytial Virus Vaccines
    • Vaccines, Attenuated
    • Viral Vaccines
    • Virology
    Personal Names

    • Rowe, Wallace, -1983
    • Sabin, Albert B. (Albert Bruce), 1906-1993
    Corporate Names

    • Children's Hospital (Cincinnati, Ohio)
    • National Institute of Allergy and Infectious Diseases. Laboratory of Infectious Diseases Branch

    Series Descriptions

    Series 1: Personal and Biographical, 1933-200811 Biographical sketches, 1993-199812 Scrapbook, 1950-197313-6 CVs and bibliography, 1987-200417 High school essays, 1940-194118 University of Chicago - correspondence, 1942-194919 University of Chicago Medical and Biological Sciences Alumni Association - reunion class of 1947 - dinner menu and yearbook, 1997110-12 University of Chicago - course notes, lab procedures, dietary formulations, 1948-1950691 Sydenham Hospital patient records, 1948Access Restrictions:

    [RESTRICTED PHI POLICY]

    113 Medical license, 1976-1994114 Army discharge, 1946115-22 U.S. Army service in Korea - correspondence, orders, data, 1949-1955693 U.S. Army - Korea - Q fever and scrub typhus, 1953Access Restrictions:

    [RESTRICTED PHI POLICY]

    123-26 University of Cincinnati College of Medicine fellow - correspondence, reports, 1950-1952127 Children's Hospital Research Foundation - correspondence, 1955-1956694 University of Cincinnati College of Medicine, 1955Access Restrictions:

    [RESTRICTED PHI POLICY]

    128-30 Johns Hopkins - correspondence, laboratory manual, notes, 1956-1957131-34 PHS Commissioned Officer - orders, correspondence, identification, retirement, 1957-1988135-37 National Institute of Allergies and Infectious Diseases Oral History Interview - conducted by Peggy Dillon, 2001-2003138 Retirement guestbook, c.2008 Family Correspondence, 1933-1995139 From Robert to his family, 1933140 From Robert to Beth Chanock, 1948-1955141 Notes, c.1950s142 Well wishes on pericarditis, 196721 Family and friends, 1968-199522 Congratulations on birth of grandson, 198323 Chanock, Foster Osgood, 1975-198024 Chanock, Frances E., 199525 Chanock, Stephen J., 1971-1989 Awards and Honors, 1945-200826 Various certificates, 1945-200827 E. Mead Johnson Award for Research in Pediatrics - congratulations and correspondence, 27 October 196428 Kimble Methodology Award - letters of congratulations and correspondence, 31 October 196629 Infectious Diseases Society of America Squibb Award - congratulations, correspondence, and acceptance speech, 25 October 1969210 DHEW Distinguished Service Medal - correspondence, photographs, and ceremony program, 15 April 1971211 Gorgas Medal - announcement and clipping, 11 December 1972212 Election to National Academy of Sciences - letters of congratulations, 1973213 Howard Taylor Ricketts Award - announcement, congratulations, event program, lecture transcript, 14 May 1973214 Award for Distinguished Achievement - announcement, 1976215 University of Chicago - honorary doctorate - announcement, photographs, and convocation program, 14 November 1977216-17 Robert Koch Stiftung Award - correspondence, letters of congratulations, ceremony program, photographs, lecture transcript, 7 December 1981218-23 ICN International Prize in Virology - announcement, correspondence, letters of congratulations, ceremony program, photographs, 7 February 1991224 Presidential Meritorious Executive Rank Award, 1993225-26 Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research - announcement, letters of congratulations, ceremony program, and clippings, 7 December 1993227 Albert B. Sabin Gold Medal Award - letters of congratulations, ceremony program, lecture transcript, and clippings, 14 September 1995228 American College of Physicians Award for Outstanding Work in Science as Related to Medicine - correspondence, May 2008 Photographs, c.1950s-2005229 Aboard the 'Independence', c.1950s230 Dr. Chanock's friends and colleagues, c.1960s-2000s231-33 Dr. Chanock - with family, in groups, in PHS uniform, at conferences, in laboratory, 1988-1998, undated234 A celebration of the career of Dr. Robert M. Chanock, Laboratory of Infectious Diseases, NIAID, NIH, 21 October 2005 Clippings, 1954-2008235-37 General, 1958-200831 Obituaries of colleagues, 1995-199832 re Influenza, 1947-199833 Virus discoveries, 1954-1980Born Digital Archive-It web archive, top results for "Robert Chanock" Google search conducted by HMD staff, 2018

    [view online]

    Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID), 1955-200834-14 NIAID Annual Reports, 1967-197241-14 NIAID Annual Reports (cont'd), 1973-198051-5 NIAID Annual Reports (cont'd), 1980-198356-13 LID Board of Scientific Counselors Review, 1978, 1981, 1984, 1987, 1992, 199661-11 LID Board of Scientific Counselors Review (cont'd), 1996, 2000, 2003, 2004612-23 LID Annual Reports [3.5 computer disks], 1966-1970; 1972-1973, 1976, 1982, 1984, 1985, 198771-14 LID Annual Reports (cont'd), 1987-199681-2 LID Annual Reports (cont'd), 1996-199783-35 Calendar - Dr. Chanock's, 1971-2006 Correspondence, 1955-2008836-50 Alphabetical by correspondent - A-H, 1957-196891-19 Alphabetical by correspondent - H-W, 1957-1968920-25 Alphabetical by correspondent - A-L, 1969-1975101-6 Alphabetical by correspondent - M-Z, 1969-1975107-24 Alphabetical by correspondent - A-T, 1975-19961025-27 Alphabetical by correspondent - A-Z, 1978-19791028 Becker, Walter B., 1963-19711029 Brown, Fred, 1989-19921030 Children's Hospital, Philadelphia - Dr. Lief, 1964-19661031 Croup agent, 1955-19581032 Fenner, Frank, 1978-19971033 Roizman, Bernard, 1974-19881034 Siim, J. Christian, 1979-19911035 Stuart-Harris, Charles, 1977-19831036 Syrucek, Lubomir, 1965-19721037 Walter Reed Army Medical Center, 1962-19691038 Wyeth Laboratories, 1964-19691039-41 Chronological Files, 1968, 1971-1972111-21 Chronological Files, 1973-1981, 1984-1986, 1989-1993, 19951122-44 Chronological miscellaneous correspondence, undated, 1957-1980121-28 Chronological miscellaneous correspondence (cont'd), 1981-2008 Correspondence of Harry Greenberg and Anthony Kalica, 1976-19831229 Greenberg, Harry correspondence - A-Z by correspondent name, 1976-19831230 Kalica, Anthony correspondence - A-Z by correspondent name, 1976-1982131 Kalica, Anthony correspondence - A-Z by correspondent name (cont'd), 1976-1982 Subjects, 1955-2007132-5 1918 Flu 2005 Avian Flu, 2002-2006136 4 New Breast Cancer Genes / DNA Variations for 7 Diseases, 2007137-8 Acambis, 1999-2007139 Adenovirus and AAV, 1964-20011310 Adjuvants for influenza virus vaccines, including use for H5N1 if needed, 20061311 Agracetus [photocopy of 1947 article], undated1312-13 Albert B. Sabin Vaccine Foundation, Inc., 1991-19941314-15 Anthrax, 1999-20041316 Anthrax incidents, hoaxes and threats, 19991317 Armed Forces Epidemiological Board (AFEB) - 50th year anniversary, 28 June 19901318-19 AFEB Commission on Acute Respiratory Diseases - annual reports, 1969, 20011320 AFEB Commission on Influenza - annual report, 19711321 Australian National University - annual reports, 1961-19671322-23 Avian flu, 2002-20071324 Biodefense NIAID, 20021325 Bioshield 5105, 20051326 Bioterrorist activities - Peter Jahrling, Ph.D. [35mm slides], 29 January 19991327 Biowarfare, 1988-19941328 Byrne, Robert J., D.V.M. - Deputy Director, Experimental Applications Branch, NIAID, 1979-19801329 Chiefs of NIAID [photographs], 2001141 Choppin, Purnell, c.1985142 Cold Spring Harbor correspondence, 1986143 Conflict of interest issues, 2005144 Consultancies - Molecular Vaccines, Inc., and Medimmune, 1988-2002145 Dangers of mutants, 1977146 Dengue - Jo Blaney, 28 November 2007147 Dengue vaccine, c.1989148 Inter-Divisional Vaccine Working Group, 17 September 1993149 Edelman memos and correspondence, 1976-19881410 Ethics - L.A. Times, September-October 20041411 Executive office NIAID, 1985-19881412 Fauci, Dr. Anthony - Director NIAID, 1985-19871413-15 Food and Drug Administration (FDA) - Panel on Review of Viral Vaccines and Rickettsial Vaccines, 19751416 Freezer repository - inventory contents, 19921417 Gallin, Dr. John - Director, Intramural Research Program, NIAID, 1985-1988 Goldberg II
    Articles sent to Dr. Chanock by journalist Billie Goldberg organized thematically.

    1418 Antivirals, 20051419 Cancer, 20051420 Dengue, 20051421 DNA vaccines, 20051422 Ebola and Marburg vaccines, 20051423 HIV SIV, 20051424 Human melanoma virus, 20051425 Immunology, 20051426 Nobel, 20051427 RNAi, 20051428 Shingles, 20051429 Aviflu, 20061430 Biodefense tick borne encephalitis virus, 20061431 HIV vaccine, 20061432 Important role of inflammation in cardiovascular disease, 20061433 Kaposi sarcoma virus receptor, 20061434 Old viruses resurrected inhuman DNA, 20061435 Osteoporosis protein diabetes genes, 20061436 Polio-Weimmer, 20061437 Prostate cancer Rx therapy, 20061438 RNAi clinical, 20061439 Max Theiler 1951, 20061440 Vertex HCV, 20061441 Vioxx Merck, 20061442 West Nile transplant patients, 20061443-44 Hartley, Janet, 1981-19941445 House hearings on influenza vaccine, August 19721446 Huebner, Robert, 1969-2002151 Huebner, Robert (cont'd), 1969-2002152 Huebner celebration, 11 November 1999153 Hybridon - contract and approval, 1994-1996154 ICN Pharmaceuticals, 1990-1991155 Infectious Disease Society of America, 1990156 Infu H5N1 DOD/NIAID, 2006-2007157 Interpretation of serologic reactions in virology - DHEW, c.1965158-9 Intracel, 2000-20011510 Intramural Research Program, 1985-19871511 Johns Hopkins Society of Scholars, 19991512 Kapikian, Albert Z. [photographs], 19841513 Krause, Richard M. - Director, NIAID, 1979-19811514 Krause, Richard M. (cont'd), 24 March 19951515 Laboratory methods in the diagnosis of viral exanthems - DHEW, c.19651516 Laboratory of Viral Diseases - annual report, 19691517 Laboratory of Infectious Diseases - history [35mm slides], 19921518 Laboratory techniques in virology - DHEW, c.19651519 Mattheis, Martha - Infectious Disease Branch, 1979-1984 MedImmune1520 General, 1998-20051521-25 General (cont'd), 1998-20051526 Adverse publicity, 19981527 Biological materials license agreement, 19961528-38 Meetings, 1989-2002161-4 Meetings (cont'd), 1989-2002165 Sales of Synagis, January-March 2000166 Molecular Vaccines, Inc., 1988-1989167 Monoclonal abs, RSV and otherwise, 1990-1994168-14 Morris, Anthony, 1973-19781615-16 Mycoplasma pneumonia and others, 1961-20021617-27 National Academy of Sciences - Committee on International Security and Arms Control (CISAC), 1988-1997171-8 National Academy of Sciences - Committee on International Security and Arms Control (CISAC) (cont'd), 1988-1997179 National Academy of Sciences - Sabin, memoirs Rowe, 19981710 National Cancer Institute - Frederick Cancer Research Facility Advisory Committee - meeting, 13 February 19871711 NIAID Animal Care Committee, 1973-19801712 NIAID Biodefense Research Agenda for Category B and C Priority Pathogens - progress report, 20041713-14 NIAID Blue Ribbon Panel on Terrorism and its Implications for Biomedical Research, 20021715-16 NIAID Clinical Research Subpanel, 1969-1980181 NIAID Clinical Research Subpanel (cont'd)182 NIAID Committee for Vaccine Development - correspondence, 1962-1967183 NIAID Extramural Activities - report, 1968184-6 NIAID Intramural Research Program - reports, 1968-1972187 NIAID Laboratory Chiefs - meeting minutes, 2002-2005188 NIAID Laboratory of Biology of Viruses - annual report, 1968189 New York City Department of Health - laboratory analysis of 1957-1958 influenza outbreak in New York City, 19591810-11 Pandemic avian flu - Secretary Leavitto's response for greater vaccine production from pharmaceutical manufacturers, 20061812 Pandemic flu preparedness, 20011813 Papilloma viruses, c.20001814-15 Parainfluenza virus, 19981816 Parainfluenza virus / glioma, 2004-20051817 Pletnev 5 yr plan, 20041818 Pneumonia, 19791819 RSV and PIV3 high risk persons: RSV LID, 1991-19921820-21 RSV pathogenesis acute and COPD (II), 19931822-26 Rowe and Huebner [photographs], 1982-19981827 Royal Danish academy of Sciences and letters - elected as foreign member, 19801828-29 Russian TBEV collaboration, 20021830-33 Sabin, Dr. Albert [photographs], 1964-2006191-7 Sabin, Dr. Albert (cont'd), 1964-2006198 Sabin poliovaccine [35mm slides], c.1986199 Sabin poliovirus vaccine clinical field trials - final report, 19611910 Sabin/Schlesinger dengue, 20031911 Scripps Research Institute, 1987-19961912 Seasonal and pandemic influenza, 20071913 Sell, Kenneth W. - Scientific Director, NIAID, 1978-19841914 Small pox, 2001-20061915 Smorodintsev adenovirus vaccine, 19691916 Society for Pediatric Research, 19931917 Sugata, Fumihiko, 19931918 Synagis, 1999-20011919 Synergistic effect when two disparate mabs are used, 2002-20061920 Tyrrell, D. A., Jr., 1970-19911921 U.S. Public Health Service - technical report on Salk poliomyelitis vaccine, 19551922 University of British Columbia, Dept. of Microbiology, Div. of Medical Microbiology - annual report, 19711923 University of Maryland - prison studies hearing, 3 September 1975 Vaccine, 1958-20061924 Adenovirus vaccine program - business case analysis, c.20061925 Vaccine development at the Laboratory of Infectious Diseases, c.20001926 Current status of vaccines for prevention of respiratory syncytial virus infection in infants and children - Peter Wright, 20031927 Licensed viral vaccines (U.S.A.), 19881928-29 Rotavirus vaccines, 2000-20061930 Virology Section - report, 19701931 West Nile and Dengue, 20031932 World Health Organization (WHO) - viral disease reports, 1958-19711933 WHO Expert Advisory Panel on Virus Diseases, 1997 Presentations on 35mm Slides, 1961-20051934 Influenza Dearborn TS1[E], undated1935 Influenza TS1, undated1936-40 Mycoplasma, undated201-2 PI Mpn epidem., undated203 Poly IC study Knopp, undated204 Respiratory Syncitial, undated205 Respiratory Syncitial Coates, undated206 Smith and Chanock Eaton vol, undated207 Mycoplasma, 1961208 Pneumonia, 1961209 Respiratory Syncytial Mpn, 19612010 Adeno caps PI, 19642011-12 Mycoplasma, c.19652013 Respiratory Syncytial and Para, c.19662014 IOM priorities and Respiratory Syncytial Virus, 19662015 Mycoplasma, c.19672016 Mycoplasma Boston, 19672017 Importance viruses and Mpn respiratory disease, 19682018 Respiratory Syncytial temperature sensitive, 19682019 Mycoplasma, 19692020 Mycoplasma pneumoniae ASM, 19702021 Mycoplasma, pneumonia, pap, 19702022 PAHO, December 19702023 Flu (temperature sensitive), 19712024 Mycoplasma, 19712025 Respiratory Syncytial Virus, 19712026 Mycoplasma NY Acad., January 19732027 Respiratory Syncytial, 19732028 Animal rights, c.19792029 Rotavirus, dengue, vaccines, etc., 1980-19812030 Long-term goals and strategy of LID research / Sabin polio vaccine, 1986-19882031 RSV, dengue, etc., c.19892032 Respiratory Syncytial, 19892033 Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries, 19902034 Respiratory Syncytial Virus vaccines, 19902035 Rotavirus, 19902036 Respiratory Syncytial Virus mabs and fabs, 1990-19952037 Respiratory Syncytial Virus, 19912038 Respiratory Syncytial Virus, 1992-19932039 Respiratory Syncytial Virus (cont'd), 1992-19932040 St. Lucia - history of respiratory, December 20002041 Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens, 20042042 Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development, 2005 Series 3: Lab Research, 1951-2008 Lab Notebooks by researcher, 1958-2000211-2 Abinanti, Francis R., 1958-1964213-19 Chanock, Robert M., 1958-2000221-19 Chanock, Robert M. (cont'd), 1958-2000231-19 Chanock, Robert M. (cont'd), 1958-2000241-4 Chanock, Robert M. (cont'd), 1958-2000245-8 Cook, M. Katherine, 1960-1975249 Dans, Peter E., 1966-19672410 Forsyth, Ben R., 1965-19662411-18 Hoggan, M. David, 1972-19852419 Johnson, Karl M., 1959-1962251-3 Johnson, Karl M. (cont'd), 1959-1962254-8 Kapikian, Albert Z., 1977-1981259-10 Lewis, Marianne, 1972-19842511-17 Mufson, Maurice A., 1962-19652518-19 Rowe, Wallace P., 1958-1972261-19 Rowe, Wallace P. (cont'd), 1958-1972271-16 Rowe, Wallace P. (cont'd), 1958-1972 Lab Notebooks by Subject, 1954-19942717 CF Antigens, 1954-19752718 Miscellaneous Virus, 19572719 Neuraminidase, 1974-1993281-8 Neuraminidase (cont'd), 1974-1993289 Radioactive Materials, 1971-19742810-16 Viral Reagents, 1962-1994 Research Data, 1950-20082817-19 Miscellaneous/Unidentified Studies, undated291-7 Miscellaneous/Unidentified Studies (cont'd), 1950-2005298 Japanese B encephalitis, 1951-1954299 Lab studies on adenovirus, pneumonia or bronchiolites, 1952-19562910 Avian Japanese B encephalitis, 1953-19552911 Transplacental transmission polio virus, 1954-19552912 Polio chick embryo, 19552913 Yale - Monkey kidney trypsinization techniques Ph colon test, 1955-19562914 Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated, 19562915 Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant, 19562916 Serology, 1956-1957699 1 RSV collation, 1956-1957Access Restrictions:

    [RESTRICTED PHI POLICY]

    2917 Croup, 1956-19592918 Pap virus, 1958-19596911 Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries, 1959-1960Access Restrictions:

    [RESTRICTED PHI POLICY]

    2919 Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island, 1959-19612920 #2 neutralization tests #19, 1959-19982921 Immunization, 1961-19626914-15 RS vaccine study, 1962-1975Access Restrictions:

    [RESTRICTED PHI POLICY]

    2922 Contribution of adenoviruses to respiratory tract illness among children, 19632923 Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4, 19632924-25 Lots of vaccine - Wyeth, 1963-19682926-27 Mycoplasma, 1963-19922928 Ludwig adeno capsule, 19642929 Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island, 1964-1965301 Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island, 1965-1966302 Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2, 1965-19706918 Children's Hospital contract reports, 1965-1981Access Restrictions:

    [RESTRICTED PHI POLICY]

    303 Drug protocols - Wyeth, 1966304 Respir. Viruses and mycoplasmas clinical: adeno field trials other, 1966-19676917 RS vaccine study, 1967Access Restrictions:

    [RESTRICTED PHI POLICY]

    305 Experimental rubella vaccine lot 12-6/6A, 1967306 Myxovirus recovery from respiratory tract illness - summary tables, 1967307 Camargo, Ena - RSV - paraflu III plaque, 1967-1972308-13 RS vaccine - Children's Hospital of D.C., 1967-19793014-16 Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth, 1968-693020 RS #3 challenge of para 1 new, November 19703017 RS ts 1 mutant - Jessup, 30 December 19693018 Clinical research protocols, 1969-19783019 RS volunteer - wild type challenge of ts1 vaccinees, 13 February 19703021 DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2, 1970-19723022 Antibody response to m. pneumoniae vaccine, 19713023 RSV clinical summary - Children's Hospital, 19713024 Virus-associated immunopathology animal models and implications for human diseases, c.19723025 RSV primates: to RS in children, c.1972-19736923 Children's Hospital - nasal washings, 1972-1974Access Restrictions:

    [RESTRICTED PHI POLICY]

    3026 Lab reports, 19733027 Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C., 19733028 Clinical observation of infants/children receiving RS-A2, ts-1 mutant, 19733029 Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory, 19743030 Safety test protocol - A/Georgia/101/74 clone 1B, 19743031 RS vaccine summaries - Children's Hospital, 1974-1975311 RSV primates: bovine RSV in cotton rats, owl monkeys and chimps, 1974-1993312 Swine influenza - Burroughs Wellcome Research Labs, 1975-1979313 Camargo, Ena - RSV, 1975-1980314 Huebner tumorigenicity TS-1-E (Morris), 1976315 Status of two dose trials, 1976316 Safety test - parainfluenza virus type 3, strain #22311 (lot F-367), 1976317 RSV primates: genetic stability - stress tests RS, 1976-1989318 Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs, 1977319 Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant, 1977-19793110 RSV primates II, 1977-19913111 Attenuated influenza vaccines, 19813112 Nasal washings - Children's Hospital, 19813113 RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps, 19813114 RSV primates: cotton rat RS, 19813115 RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps, 19823116 RSV primates, 1982-19933117 Research labs - Merck Sharp and Dohme, 1983-19913118 SV40, 1983-20013119-20 Production protocols - Wyeth, 19853121 RSV hr mutants in primates ts in primates: primates studies RSV, 1986-19903122 Immunization: flavi and alpha viruses, 19883123 Prophylactic effect antibodies, 18 October 19883124 MF59 Chiron, 1989-20063125 RSV vaccine testing, 1989-20063126 Fourth NIH rotavirus vaccine workshop, 5-6 November 19903127 RSV ICN Krugman, 1991-19933128 Flavivirus vaccine research - Walter Reed-NIAID, 1991-19943129-30 RSV human fob monoclones, December 1991-February 19953131 CA influenza virus - Wyeth, 1992-19933132 RSV - Repligen, 19933133 Fab 19 MARM, 1993-19953134 RSV human FABS, 5 February 19953135-36 AGMK cells, karyotype, tumor tests, patent, 1994-2000321-3 Bovine RV (4x) clinical trial, 1997324 U.S.-Russian collaboration final report, 1997325-7 TBEV LGT, 1998-2000328-9 TBEV II and West Nile, 20003210 History of discovery and development of successful interventions, 20003211 West Nile virus, 2000-20063212 Periodic dengue, West Nile, TBEV meetings, 20013213-14 Dengue vaccine part II, 2001-20073313 Dengue virus and West Nile virus, 20083215 Dengue virus vaccine development, 2002331 TBEV and Langat II, 2002332 Dengue virus vaccine data, 2003333 Restoration of live adenoviruses vaccine in DOD, 2003-2005334-6 Negative SV40, 2004337-8 Positive SV40, 2004339 Dengue virus vaccine development, 20043310 Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity, 20053311 Dengue candidates, August 20063312 Den langat, 2006 LID Lab Research Reports, 1960-20043314-27 Clinical research projects, 1960-19823328 NIAID ad hoc contract review, 19733329 Experimental immunoprophylaxis against respiratory syncytial virus infections in primates, undated3330 Experimental infection of primates with respiratory syncytial virus, undated3331 Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus, undated3332 Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants, undated3333 RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research, 19683334 Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections, 19693335 Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age, 19693336 Serum complement in acute bronchiolitis, 19693337 Pediatric adenovirus vaccine evaluations, 19713338 Fort Detrick reports, 1972-1977341 Chanock scientific studies, 1973-1992342 Transferring viruses to NIAID, 1997-1998343 Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section, c.2000344-5 Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section, 2000-2001346 Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers, 2001347 Projected schedule for WNV/DEN4 chimera studies, 2001348 New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus, 2003349 The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section, 20043410 In vitro models of paramyxovirus infection, 20043411 New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section, 20043412 NIAID 69-A - Study of non-bacterial respiratory disease A) children, 1966-19693413 NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis, 19663414 NIAID 69-C - The etiology of acute respiratory disease in civilian adults, 19653415 NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines, 19663416 NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness, 19663417 NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin, 19663418 NIAID 70-C - Basic studies on mycoplasma, 19663419 NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO), 19663420 NIAID 70-D - Laboratory studies of viral hepatitis agents, 19663421 NIAID 70-E - Biological and biophysical studies of rhinoviruses, 1966-19693422 NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers, 1969 Investigational New Drugs (IND), 1963-20013423 Unnumbered - Attenuated quadrivalent human-bovine (UK) rotavirus reassortant vaccine - original submission, 19953424 Unnumbered - Wild-type and attenuated respiratory syncytial viruses; subgroup B, 19933425 IND #24 - Parainfluenza type 3 vaccine - suppl. 1-4, 1963-19673426-31 IND #71 - Live adenovirus type 4 enteric vaccine - suppl. 31-50, 1967-19723432-35 IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24, 1964-1973351-2 IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24 (cont'd), 1964-1973353 IND #385 - Monovalent adenovirus type 2 soluble antigen vaccine, aqueous or alum absorbed - suppl. 1, 4-6, 1969-1971354 IND #386 - Live, attenuated rubella virus vaccine strain HPV-79-RK 7, lot 31764 - suppl. 2-3, 1969355 IND #401 - Meningococcal group C vaccine - suppl. 1-36, 1969-1973356-7 IND #419 - Complexed polyinosinic and polycytidylic acids - suppl. 1-13, 1969-1970358-9 IND #421 - Parainfluenza 3 challenge pool (attenuated?) - suppl. 1-23, 1969-19733510 IND #437 - Pneumococcal polysaccharide vaccines, 1970-19723511 IND #450 - Vaccinia virus vaccine -suppl. 7, 19713512 IND #582 - H. Influenzae type b PRP vaccine - suppl. 10, 188, 1972-19873513-20 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399, 1972-1995361-17 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995371-18 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995381-18 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995391-18 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995401-18 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995411-3 IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995414-5 IND #734 - TS mutants of mycoplasma pneumoniae - suppl. 1-1C (inactive), 1974-1977416 IND #735 - Inactivated monovalent influenza B virus vaccine, 1973417-8 IND #825 - Inactivated influenza A virus vaccines subunit - suppl. 1-30, 1974-1980419 IND #839 - Poly I; poly C: poly-l-lysine - suppl. 1, 19744110 IND #1044 - Live parainfluenza virus vaccines types 1, 2, and 3, placebo - suppl. 1-8 (inactive), 1975-19784111-19 IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51, 1976-1980421-6 IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51 (cont'd), 1976-1980427 IND #1287 - Adenovirus subunit vaccines - suppl. 1-11, 1978-1982428-17 IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118, 1978-1990431-17 IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118 (cont'd), 1978-19904318 IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37, 1979-1993441-5 IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37 (cont'd), 1979-1993446 IND #1462 - Varicella virus vaccine - suppl. 123, 1987447-20 IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139, 1980-1998451-15 IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139 (cont'd), 1980-19984516 IND #1808 - E. coli CFA/II pili vaccine oral - suppl. 4, 19854517 IND #1914 - Interferons - suppl. 9-10, 19854518 IND #2000 - Vi capsular antigen - suppl. 4, 19854519-21 IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63, 1988-1995461-7 IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63 (cont'd), 1988-1995468-10 IND #2858 - Bovine parainfluenza virus type 3 - suppl. 1-30, 1988-19944611-14 IND #4006 - Rhesus rotavirus vaccines, live, (tetravalent, serotypes 1, 2, 3, and 4) oral - suppl. 1-25, 1988-19984615-19 IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58, 1993-2000471-5 IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58 (cont'd), 1993-2000476-9 IND #4981 - Respiratory syncytial virus subgroup B (strain 14617, vero 1 cells) wild type and attenuated live vaccines - suppl. 1-33, 1993-20004710 IND #7762 - Respiratory syncytial virus, live, attenuated vaccine and purified fusion protein with alum - suppl. 1-6, 8-9, 1998-2001 Research Contracts, 1952-2001 Proposals, 1955-20014711 Unidentified, undated4712 Etiology of viral diarrheas - part III, undated4713 To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg, 19554714 Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., c.19644715 The isolation of viruses and viral subunits, 19644716 Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures, c.19654717 Studies on adenovirus vaccines, c.19654718 Biochemical and immunologic investigations of neisseria meningitidis, 19654719 Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae, 19654720 To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., 19654721 Concentration of human hepatitis virus (supplement to NIAID Support of Man program), 19664722 Proposed vaccine studies, Kansas City, 19664723 Respiratory virus vaccines, 19674724 Tests in infants and children for antigenicity and effectiveness of inactivated vaccines, 19674725 X-ray crystal structure of adenovirus coat protein, 19694726 Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 19714727 Studies on hemophilus influenzae b vaccine, c.19724728 Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization, 19744729 Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells, 19754730 Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection, 19754731 Protective efficacy of langat virus vaccines in mice - animal study proposal, 19974732 Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal, 19994733 Evaluation of chimeric TBEV/DEN4 virus vaccines in mice, 20014734 Immunogenicity and protective efficacy of langat virus vaccines in mice, 2001 Reports, 1952-19984735-39 National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati, 1952-19564740 Vaccine development program commitments, 19654741 Respiratory vaccine development, 19664742 Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory, 19674743 NIAID Molecular Anatomy Program, 19674744 Evaluation of a live type 4 adenovirus vaccine, 1967-19684745 Acute infectious nonbacterial gastroenteritis, 19734746 103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies, 1964-19654747 6-61-03-032 - Studies on virus and rickettsial diseases, 19534748 263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions, 19814749 263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions, 19814750 3A014501B71Q - Communicable diseases - immunology, c.19664751 DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines, 19634752 DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus, 19654753 DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections, 19654754 DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus, 19674755 DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus, 19714756 DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus, 19714757 M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits, 1972481 NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines, 1970482 NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines, 1970483 NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1969484 NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines, 1971485-6 NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971, 1973487 N01-AI-01528 - New viruses in relation to clinical diseases, 1968-1972488-9 N01-AI-02638 - Operation of a virus vaccine production laboratory, 1980-1981, 1983-19874810 N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals, 19814811-13 N01-AI-05057 - University of Puerto Rico, 1991-19924814-15 N01-AI-05067 - Care and housing of AIDS research animals, 1990-19914816 N01-AI-17757 - Children's Hospital, 1980-19814817-19 N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults, 1972-19894820 N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains, 19744821 N01-AI-22508 - Clinical evaluation of influenza virus vaccines, 19744822 N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . ., 1993-1994491-2 N01-AI-32521 - Operation of a virus laboratory in support of LID, 1974-1990493-4 N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity, 1978495 N01-AI-42528 - Influenza research center, 1979496 N01-AI-52565, 1985-1987497-8 N01-AI-72535 - Establishment of an infectious enteric disease study, 1978-1979499-10 N01-AI-82681 - Operation of an experimental virus vaccine production laboratory, 1988-19894911 N01-AO-52703 - Care and housing of AIDS research animals, 1997-19984912 N01-AO-52706 - Facility for non-human primates utilized in infectious disease research, 19984913 PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture, 19664914 PH-43-62-80 - Production of enterovirus antisera, 19654915 PH-43-62-127 - Preparation of immune serum to enteroviruses, 19654916 PH-43-62-129 - Standardization of picornavirus immune sera, 19654917-26 PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine, 1962-19704927-29 PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance, 1966-19684930-32 PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines, 1966-19684933 PH-43-62-839 - Preparation of mycoplasma antigene and antisera, 19654934-35 PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children, 1968, 19704936-38 PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population, 1966-1968501-4 PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species, 1964-1966505-6 PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses, 1965, 1967507 PH-43-63-81 - Development, growth and characterization of virus induced tumor cells, 1967508 PH-43-63-90 - Upper respiratory virus, 1965509 PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory, 19665010-11 PH-43-63-562 - Prevention of viral respiratory infections, 1964, 19685012 PH-43-63-563 - Vaccine studies in a children's center, 19685013 PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection, 19675014-16 PH-43-63-582 - Respiratory disease vaccine, 1962-19675017-18 PH-43-63-1128 - Surveillance of respiratory infections in an industrial population, 1966, 19685019-20 PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population, 1967-19685021 PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus, 19645022 PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses, 19655023 PH-43-63-1177 - Reference seeds for echo and coxsackieviruses, 19655024 PH-43-64-529 - Preparation and development of viral reagents, 19655025-27 PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis, 1966, 1968, 19725028-29 PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine, 1966-19675030-32 PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs, 1965-19675033-34 PH-43-65-562 - Rhinovirus reference laboratory, 1966-19675035-36 PH-43-65-563 - Studies of RSV vaccines, 1966-19675037 PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents, 19685038-40 PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections, 1966-19685041 PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers, 19665042-43 PH-43-66-93 - Rubella vaccine development, 1967-19685044 PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines, 19675045 PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines, 19685046-47 PH-43-66-461 - Research and development of an inactivated rubella virus vaccine, 1967-19685048 PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents, 19665049 PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man, 1966-19685050 PH-43-66-565 - Development of a live vaccine for human influenza, 19665051-52 PH-43-66-917 - The role of infection in precipitating sudden deaths in infants, 19695053-54 PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions, 1967-19685055 PH-43-66-970 - Operation of a tissue culture developmental laboratory, 19675056 PH-43-66-971 - Provide for the operation of a serology laboratory, 19675057-58 PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children, 1968, 19705059-60 PH-43-67-75 - The testing of rubella virus vaccines in human volunteers, 1967-19685061 PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus, 19685062 PH-43-67-77 - Biologic and antigenic studies with rubella virus, 19685063 PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines, 19685064-65 PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines, 19675066 PH-43-67-80 - Studies of rubella vaccine efficacy, 19675067 PH-43-67-91 - Research and development of respiratory disease vaccines, 1967-19685068 PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines, 19735069 PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis, 19695070-71 PH-43-67-745 - Studies of local antibody in respiratory viral immunity, 1967, 19695072 PH-43-68-81 - Operation of a rubella virus service laboratory, 19685073 PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein, 19685074 PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines, 1968511-4 PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses, 1968-1975515-6 PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1968-1969517 Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus, 1977518 Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus, 1978-1981 Cooperative Research and Development Agreements (CRADA), 1972-2003519 License agreements, 1988-19965110-11 Chiron, 1988-20035112-15 Intracel, 1995-19975116-21 Lederle, 1992-2000521-10 Lederle (cont'd), 1992-20005211 MedImmune, 20025212 Praxis, 1987-19885213 Upjohn, 19885214-27 Wyeth, 1972-2001531-5 Wyeth (cont'd), 1972-2001 Series 4: Patents, 1966-2008536-7 Chanock's patents, 1967-2000538-10 Patent status reports, 2002-20085311 Confluent growth of mycoplasma - application, 1966-19675312-15 #3,317,393 - Immunization by selective infection of the intestinal tract with an encapsulated live virus, 1967-20055316-17 #3,992,522 - Temperature sensitive recombinant mutant viruses and a process for producing same, 1974-19765318 #4,552,757 - Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus, 1984-19885319-20 #4,571,385 - Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors, 1995-19995321-29 #4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth), 1998-2005541-4 #4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth) (cont'd), 1998-2005545 #4,751,080 - Vaccine against rotavirus diseases, 1988546-9 #4,800,078 - Immunotherapeutic method of treating respiratory disease by intranasal administration of IGB, 1966-19935410 #5,646,033 - African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines, 19975411-18 #5,762,905 - Human neutralizing monoclonal antibodies to respiratory syncytial virus, 1995-20045419 #5,882,651 - Attenuated respiratory syncytial virus vaccine compositions, 19935420 #5,911,998 - Method of producing a virus vaccine from an African green monkey kidney cell line, 19995421 #5,922,326 - Attenuated respiratory snycytial virus vaccine compositions, 19935422 #6,117,667 - Method for producing an adapted virus population from an African green monkey kidney cell line, 20005423-33 #6,184,024 - Chimeric and/or growth restricted flaviviruses, 1992-2007551-2 #6,184,024 - Chimeric and/or growth restricted flaviviruses (cont'd), 1992-2007553-9 #6,497,884 - Chimeric vaccine against tick-borne encephalitis virus, 2000-20075510 #6,660,273 - Chimeric vaccine against tick-borne encephalitis virus, 20035511-12 #6,676,936 - Chimeric and/or growth-restricted flaviviruses, 1998-19995513-19 #6,794,174 - Full-length infectious cDNA clones of tick-borne flavivirus, 2001-20085520 #7,150,984 - Attenuated human rotavirus vaccine, 20065521 #7,364,737 - Human neutralizing monoclonal antibodies to respiratory syncytial virus, 20085522-25 #7,932,074 - Multivalent human-bovine rotavirus vaccine, 1998-20065526-28 #8,778,671 - Construction of West Nile virus and dengue fever chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus, 2001-2004 Series 5: Writings/Reprints, 1953-20075529 Chanock numbered bibliography (1-653), 2003 Numbered Articles by Dr. Chanock, 1953-20035530-34 1-5, 1953-1954561-144 6-151 [incomplete], 1954-1967
    [missing 127, 149]

    571-148 152-323 [incomplete], 1967-1976
    [missing 169, 194, 200, 203, 209, 219, 221, 230, 236, 247, 250, 252-253, 257, 259, 290, 291, 293-295, 301, 310, 315, 319]

    581-194 325-568 [incomplete], 1976-1989
    [missing 330, 340, 342, 348, 350, 364, 370, 384, 396, 411, 443-444, 449-450, 460, 464-465, 467, 470, 471, 474-477, 479, 481-482, 502-503, 505, 509, 524-525, 527, 532, 534, 537, 540-542, 546, 551-552, 557-558, 560, 563-566]

    591-46 570-653 [incomplete], 1989-2003
    [missing 574, 576, 579-581, 584, 586, 589-594, 597-600, 602, 605, 608, 611-612, 615, 618, 620-623, 625, 629-630, 641-644, 647-649]

    Unnumbered Reprints by Dr. Chanock, 1954-20055947 Respiratory syncytial vaccine - with Murphy, Collins, and Olmsted, undated5948 Recovery and characterization of hemagglutinins from two immunologically distinct types of dengue virus - with Sabin and Sweet, c.19545949 III. Production of illness and clinical observations in adult volunteers, 19615950 Primary atypical pneumonia, 19665951 Genetic approaches to the prevention of influenza A virus infection - with Murphy, 19815952 Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus - with Hendry, Burns, Walsh, Graham, Wright, Hemming, Rodriguez, Kim, Prince, McIntosh, and Murphy, 19885953 Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides - with Markoff, Bray, Lai, Eckels, Summers, Gentry, Houghten, and Lerner, 19885954 Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev, 2005 Drafts by Dr. Chanock, c.1960s-c.20075955 Untitled fragments, undated5956 Acute respiratory disease of infancy and childhood - present understanding and prospects for prevention, undated5957 Blueprint for use of live virus vaccine to prevent a pandemic of influenza A virus - with Murphy and Spring, undated5958 Decreased virulence and protective effect of a genetically stable temperature-sensitive mutant of m. pneumoniae in human volunteers, undated5959 Infection of immature white mice by the addition of western equine encephalitis virus to the feed, undated5960 Parainfluenza, respiratory syncytial, and New Castle disease viruses - with Parrott (title page only), undated5961 Development of immunity - outline, c.1960s5962 Prospects for control of auto viral mycoplasmal respiratory tract disease by vaccination, c.1960s5963 Untitled draft re pediatric respiratory illnesses at Camp Lejeune 1959-1963, c.19645964 The contribution of adenoviruses to respiratory tract illness among children, c.19655965 The relationship of mycoplasma pneumoniae to pediatric respiratory tract disease - with Canchola, Brandt, Kim, and Parrott, 19705966 Guide for the collection and transport of virological specimens, 19755967 Virus and mycoplasma pneumoniae in respiratory disease patients, January 1975-June 1976 - with Brandt, Kim, Arrobio, and Parrott, c.19775968 Isolation and characterization of temperature-sensitive mutants of influenza A virus, 19775969 Bovine respiratory syncytial virus: studies in experimental animals - with Prince, Suffin, Horswood, Camargo, Prevar, and Sly, 19805970 Respiratory syncytial virus in cotton rats: growth, antigenicity and protective efficacy of two temperature-sensitive, live virus vaccine candidates, ts-1-NG-1 and ts-1-NG-16 - with Prince, Horswood, Prevar, Camargo, Suffin, and Spring, 19805971 HLA antigens in severe respiratory syncytial virus disease in infants and early childhood - with Johnson, Kiim, Hartzman, Parrott, Woody, and Sell, 19815972 Studies of avian-human reassortant influenza A viruses in seronegative (HAE<1:8) adult volunteers, 1984-86 - with Clements, Murphy, Snyder, Buckler-White, Tierney, Betts, Dolin, Black, and Sears, 19865973 Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations, 19915974 A live cold-passaged temperature-sensitive mutant of human respiratory syncytial virus is highly attenuated, genetically stable, immunogenic, and efficacious against wild type challenge in seronegative chimpanzees, 19935975 "Cold-passaged and temperature sensitive (ts) derivatives of the partially attenuated respiratory syncytial virus ts-4 mutant are more restricted in replication in mice - with Crowe, Jr., Hsu, Lubeck, and Murphy, c.19945976 Short summary of studies of chimeric viruses as candidates for live attenuated vaccine against tick-borne encephalitis, 2000-20055977 Comparison of live and inactivated tick-borne encephalitis virus vaccines for immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev, 20055978 Early experiences with influenza adjuvated vaccines, c.2007 Untitled Drafts by Dr. Chanock, c.1955-c.20075979 Miscellaneous individual pages, undated5980 The interplay of immunologic factors in acute viral respiratory tract disease, undated5981 pages 16-22 re ts mutants, undated5982 There is compelling evidence that local immunity plays a major role in resistance to most respiratory viral pathogens, undated5983 re temperature-sensitive mutants, undated5984 re vaccines against RSV, undated5985 re arthropod-borne encephalitis viruses, c.19555986 pages 3-15 re RS virus, c.19625987 report on tests of inactivated respiratory virus vaccines, c.1967-19685988 mycoplasma pneumoniae, 19735989 RS virus (RSV) is the major viral pathogen of the respiratory tract, 19755990 Respiratory syncytial (RS) virus is the major etiologic agent of bronchiolitis, 19765991 pages 25-90 of "f-rot.doc", 19895992 Evaluation of antibody response to RSV, 19905993 pages 9-29 re serum RSV antibodies, c.19945994 re vaccine against TBEV, c.20025995 re Langat virus (LGT) - with Kyle, 20025996 re flaviviridae tick-borne encephalitis viruses (TBEV), 20045997 re protective immune response against 1918 influenza virus, c.2007 Books Inscribed to Dr. Chanock, 1998-2004601 Textbook of Military Medicine - Part I Warfare, Weaponry and the Casualty, 1998602 Hantavirus hunting - by Ho-Wang Lee, 2004 Series 6: Meetings, 1954-2005603 Proceedings of the Conference on Complement Fixation, 5 August 1954604-5 Proceedings of the Conference on Neutralization, 18-20 May 1955606 Proceedings of the Round Table Conference on Genetic Aspects of Virus-Host Cell Relationships with Particular Reference to Polioviruses, 23-24 February 1956607 Society for Pediatric Research annual meeting, 8-9 May 1959608 Meetings - general, 1960609 Meetings - general, 19616010-11 Russian trip, May 19616012 Meeting in Prague, Czechoslovakia, 23-27 May 19616013 World Health Organization, Geneva, 15-21 August 19616014 Meetings - general, 19626015 International Postgraduate Course Respiratory Virus Diseases, 11-14 April 19626016 Newer Respiratory Disease Viruses, 3 October 19626017 Meetings - general, 19636018 World Health Organization Respiratory Virus meeting, 1-6 July 19636019 University of Wisconsin Symposium on New Castle Disease, 15 July 19636020 7th International Congress on Tropical Medicine, 1-11 September 19636021 Seminar on Respiratory Disease, 9 October 19636022 Meetings - general, 19646023 American College of Physicians, 6-10 April 19646024 World Health Organization directors, 20-27 July 19646025 Meetings - general, 19656026 Rhinovirus workshop, 25 January 19656027 American Society of Clinical Investigation, 3 May 19656028 World Health Organization, 27 September 19656029 Armed Forces Epidemiological Board Commission on Viral Infections, 14-15 October 19656030 International Congress of Pediatrics, 7 November 19656031 Conference on Acute Infectioius Respiratory Diseases, 14-15 December 19656032 Meetings - general, 19666033 Mycoplasma conference, 9-11 February 19666034 American Society for Clinical Investigation, 1 May 19666035 New York Academy of Science, 11 May 19666036 Conference on Live Oral Adenovirus Vaccine in Marine and Navy Recruits, 10-11 June 1966611 Pan American Health Organization, 7 November 1966612 Meetings - general, 1967613-4 Human Vaccines - Possible Oncogenic Implications, 9 January 1967615 Laboratory Methods in the Isolation and Identification of Respiroviruses and Enteroviruses, 3-4 July 1967616 Respiratory Syncytial Virus Workshop, 10 July 1967617 Conference on Measles Virus, etc., 13 September 1967618 Scientific Group on Respiratory Viruses, 9-14 October 1967619 American Academy of Pediatrics, 25 October 19676110 Symposium honoring Dr. M. D. Eaton, 1 December 19666111 Meetings - general, 19686112 Clinical at the College of Physicians and Surgeons, Columbia, University, 27 January 19686113-14 Gustav Stern Symposium on Perspectives in Virology, 29 January 19686115 American Academy of Allergy, 5-7 February 19686116 American Epidemiological Society, 29-30 March 19686117 American Medical Association, 23-24 April 19686118 American Society for Clinical Investigation, 5 May 19686119 Society for Epidemiological Research, 10-11 May 19686120 Postgraduate Workshop, University of Maryland, 2 June 19686121 Third International Symposium on Aerobiology, 15-19 September 19686122 Influenza Genetics, 11-12 November 19686123 Armed Forces Epidemiological Board Committee on Influenza, 18-20 November 19686124 Twelfth International Congress of Pediatrics, 1-7 December 19686125 Meetings - general, 19696126 Vaccine Development Committee meeting, 27-28 January 19696127 International Conference on Rubella Immunizations, 18-20 February 19696128 Conference on Immunology, 2 April 19696129-30 World Health Organization Virus Reference Centres meeting, 22-25 April 19696131 American Society for Microbiology, 4-9 May 19696132 American Society for Clinical Investigation, 5 May 19696133 American Thoracic Society, 24-26 May 19696134 Gustav Stern meeting, 25-26 May 19696135 Ad hoc Conference on Australia Antigen and Hepatitis, 23-24 June 19696136 Vaccine Development Workshop on Vaccine Testings, 27 June 19696137 Virus Diseases of the Respiratory Tract, 23 September 19696138 International Working Conference on Influenza, 14-16 October 19696139 Infectious Disease Society of America, 25-26 October 19696140 International Conference on Vaccines against Viral and Rickettsial Diseases of Man, 7-11 November 19696141 Committee on Influenza, 17-19 November 19696142 NICHD Immunology Workshop, 11-13 December 19696143 Secretory Antibody, 10-13 December 19696144 Human Responses to Viral Antigens, 3 August 19716145 Mycoplasma and Mycoplasma-like Agents of Animal and Plant Diseases, 8-10 January 19736146 Influenza Workshop IV, 24 January 19736147 Acute Respiratory Diseases, 8-9 March 19736148 Influenza Vaccines, University of Maryland, 13 March 19736149 Fogarty Center Conferences on Preventive Medicine, 15-16 March 19736150 ICN/UCLA Symposium on Molecular Biology-Virus Research, 18-23 March 19736151 New Approaches for Inducing Natural Immunity to Pyogenic Organisms, 20-23 March 19736152 Influenza Workshop V on Influenza Vaccines, 3-4, 14 April 1973621 Influenza Workshop V on Influenza Vaccines (cont'd), 3-4, 14 April 1973622 American Epidemiological Society, 6-7 April 1973623 Epidemic Intelligence Service Conference, 9-13 April 1973624-5 Directors of World Health Organization Reference Centers, 16-19 April 1973626 U.S.-Japan Program, 23-27 July 1973627-8 Problems of Bacteriophage Contamination, 1 August 1973629 FIC Subcommittee on Infectious Diseases, 14-16 September 19736210 Infectious Diseases Society of America, 17-18 September 19736211 Parainfluenza and RS Candidate Vaccines, 5 October 19736212 Animal Influenza and its Significance for Human Infections, 11-12 October 19736213 University of Chicago Alumni Banquet, 23 October 19736214 National Academy of Sciences, 23 October 19736215 Interagency Meeting on Influenza, 19 November 19736216-17 World Health Organization, 1-5 September 19756218 Joint Working Conference of the Virus Cancer Program, 3-5 November 19756219 Influenza meeting, NIH, 12 January 19766220 Influenza Program Review meeting, NIH, 15-16 January 19766221 Working Group on Pandemic Influenza, 26-28 January 19766222 Bacterial and Viral Gastroenteritis, 5-6 February 19766223 Bureau of Biologics, 20 February 19766224 Walter Reed Ad Hoc meeting, 8 March 19766225 Armed Forces Epidemiological Board, 12 March 19766226 Bureau of Biologics, 25 March 19766227 Current Status and Prospect for Improved and New Bacterial Vaccines, 29 March-1 April 19766228 Influenza meeting, NIH, 15 April 19766229 National Academy of Sciences, 26-28 April 19766230 American Epidemiological Society, 29 April-1 May 19766231 Association of American Physicians, 30 April-2 May 19766232 American Society for Microbiology, 2-7 May 19766233 Association of American Physicians, 4 May 19766234 Conference on Persistent Viral Infections, 13-16 June 19766235 Bureau of Biologics, 21-22 June 19766236 Bronchiolitis workshop, 28-29 June 19766237 Festschrift for Albert Sabin, 26 August 19766238 Consensus Development on Use of Amantadine, 15-16 October 19766239 Infectious Disease Society of America, 25-26 October 19766240 Ad Hoc Viral and Rickettsial Disease Study Group, 8 November 19766241 Viral and Bacterial Vaccines, Present Knowledge and Future Development International Symposium, 7-8 September 19776242 Chinese delegation, 19796243 Experimental Herpesvirus Vaccine workshop, 7-9 February 19796244 Surgeon General's Meeting on Influenza, 12 February 19796245 Medical Research Council, 20 February 19796246 Symposium on Potentiation of Immune Response to Vaccines, 20-21 February 19796247 The Royal Society Meeting on Influenza, 21-22 February 1979631 Secretary's Conference on Influenza, 6 March 1979632 Attenuated Influenza Vaccine workshop, NIH, 9 March 1979633 American Physicians Fellowship Program, NIH, 29-30 March 1979634 American Epidemiological Society, 30-31 March 1979635 Vaccine Studies in the Elderly, 30 April 1979636 American Society for Microbiology, 4-11 May 1979637 Influenza B Viruses workshop, 30-31, 1979638 Prevention of Major Infectious Diseases: Current Concerns and Future Promise, 20-21 September 1979639 Medical Society of the District of Columbia, 27-28 September 19796310 Infectious Diseases Society of America, 5-6 October 19796311 Molecular Approaches to Vaccine Development, 10 October 19796312 U.S.-U.S.S.R. Influenza meeting, 16-18 October 19796313 Genetic Variation of Viruses, 28-30 November 19796314 Australian Commonwealth Scientific and Industrial Research Organization, 10-12 December 19796315 Perspectives in Virology, 4-5 February 19806316 Australian Academy of Science, 8-12 February 19826317 Duke University seminar, 4 February 19806318 Attenuated Vaccines, 10 March 19806319 Pritzker School of Medicine Council meeting, 2 May 19806320 American Society for Microbiology, 11-16 May 19806321 Eradication of Infectious Diseases, 27-28 May 19806322 Infectious Disease Society of America, 25-26 September 19806323 Negative Strand Viruses, 27 October-1 November 19806324 World Health Organization Consultation on Influenza, 5-6 November 19806325 Department of Microbiology and Molecular Genetics seminar, 2 December 19806326 ICN/UCLA Symposium on Genetic Variation of Influenza Viruses, 8-13 March 19816327 International Symposium on Viral Hepatitis, 30 March-2 April 19816328 Department of Microbiology and Immunology seminar, Duke University, 16 April 19816329 Mt. Sinai Symposium on Infections Caused by Enteric Viruses, 4 June 19816330 International Congress of Virology, 2-7 August 19816331 Respiratory Diseases meeting, 16 October 19816332 Workshop on Respiratory Diseases, 21-22 June 19826333 International Symposium on Polilomyelitis Control, 14-17 March 19836334 NIAID Workshop on AIDS, 5-6 April 19836335 Towards New Vaccines Against Virus Infections, 21-23 June 19836336 London Conference on Influenza, 21-23 September 19836337 Association of American Physicians, 29 April-2 May 19836338-47 Modern Approaches to Vaccine, 31 August-4 September 19836348 Negative Strand Virus meeting, 11-17 September 19836349 International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections, 9-12 October 19836350 19th Immunization Conference - proceedings, 21-24 May 19846351 International Congress of Virology, 1-7 September 19846352 International Workshop on the Molecular Biology of Flaviviruses, 29 November-1 December 19846353 Status of Attenuated Influenza Vaccines, 10-11 December 19846354 Rowe Symposium, 11-12 February 19856355 Rotavirus Vaccine Work Group, 13 March 19856356 Genetically Altered Viruses, 28 April-1 May 1985641 American Society for Virology, 21-25 July 1985642 World Health Organization Steering Committee on Acute Respiratory Viruses, 29-30 July 1985643-5 Modern Approaches to Vaccines, 11-15 September 1985646 The Biology of Negative Strand Viruses, 15-20 September 1985647 Expression of Foreign Genes, 4-7 October 1985648 RSV Symposium, 16 October 1985649 Duke University Academic Visiting Professor, 16-18 December 19856410 Scripps Scientific Review Committee, 13-15 January 19866411 Rowe Symposium, 3-4 February 19866412 Vaccinia-Vectoring, 31 March 19866413 Cosmos Club award, Albert Sabin, 15 April 19866414 Vaccine Supply and Innovation workshop, 24-25 April 19866415 Association of American Physicians, 2-4 Mary 19866416 Influenza Viruses, 20 May 19866417 World Health Organization Acute Respiratory Viruses meeting, 27-28 June 19866418 FEBS meeting, 24-29 August 19866419 Infectious Diseases Society of America, 2-3 October 19866420 Scripps Scientific Review Committee, 10 January 19876421 Rowe Symposium, 2-3 February 19876422 AIDS Vaccines workshop, 25-27 March 19876423 Workshop on Respiratory Syncytial and Parainfluenza Viruses, 4-5 May 19876424 Scholars-in-Residence symposium, 11-14 May 19876425 Pasteur Centenary Symposium, 26-28 May 19876426 American Society for Virology, 31 May-4 June 19876427 International Conference on AIDS, 1-5 June 19876428-29 Nobel Symposium on the Vaccines of the Future, 23-26 August 19876430 International Symposium on Infectious Diseases, 11-12 November 19876431 Live Viral Vaccines for Respiratory and Enteric Tract Diseases, 24 November 19876432 Conference on the Development of Vaccines Against HIV and AIDS, 14-15 December 19876433 Scripps Scientific Review Committee, 14 January 19886434 Conference on Poliomyelitis Vaccines: Re-evaluating Policy Options, 21-22 January 19886435 Rowe Symposium, 1-2 February 19886436 National Academy of Sciences Committee on International Security and Arms Control, 16 March 19886437 Oral Immunization symposium, 21-22 March 19886438 NIH Seminar, 6 April 19886439 American Pediatric Society Centennial Celebration, 3 May 19886440 National Academy of Sciences and Academy of Sciences of the USSR on Biological Weapons, 9-11 May 19886441 Wagner Symposium, 15-16 May 19886442 Live Attenuated Influenza Virus Vaccine, 26 May 19886443 American Society for Virology, 12-16 June 19886444 NIH Rotavirus Vaccine workshop, 8-9 September 19886445 Modern Approaches to New Vaccines Including Prevention of AIDS, 14-18 September 19886446 Immunology of Virus Diseases, 26-28 October 19886447 Genetic Basis of Human Disease, 30 November-1 December 19886448 Institute of Medicine Research Briefing Panel, 27-28 April 19896449 Symposium on Respiratory Virus Vaccine Development, 1 May 19896450 American Society for Virology, 9-13 July 19896451-52 Modern Approaches to New Vaccines Including Prevention of AIDS, 20-24 September 19896453 International Conference on Comparative and Applied Virology, 15-21 October 19896454 Rowe Symposium, 5-6 February 19896455-56 American Thoracic Society, 23 May 1990651 American Thoracic Society (cont'd), 23 May 1990652 International Congress of Virology, 26-31 August 1990653 Children's Vaccine Initiative, 6 August 1990654 Colloquium on Human Diseases - Molecular Mechanisms of Viral Pathogenesis, 19-20 October 1990655 Animal Models of Respiratory Syncytial Virus Infections, 24-25 October 1990656 NIH Rotavirus Vaccine Workshop, 5-6 November 1990657 Rowe Symposium, 4-5 February 1991658 Saul Krugman Festschrift, 12 April 1991659 Inauguration of Richard M. Haidack Distinguished Professorship in Medicine, 29 May 19916510 Pathogenesis Symposium, 5 December 19916511 Rowe Symposium, 3-4 February 19926512 NIAID Interdivisional AIDS Working Group, 24 April 19926513 Measles workshop, 14-15 September 19926514 Lounsbury Award Jury Dinner, 5 November 19926515 Innovations in Therapy of Human Viral Diseases, 6-7 December 19926516 Molecular Pathogenesis of Infections and Tumors, 5-6 May 19946517 Scientific Symposium to Honor the Work of Janet W. Hartley, 13 September 19946518 Scientific Meeting of the Australian Society for Microbiology, 26-30 September 19946519 Molecular Approaches to the Control of Infectious Diseases, 5-9 October 19946520-21 Frank and Bobbie Fenner Conference in Medical Research, 28-30 November 19946522 Office of Science and Technology Policy meeting, 29 March 19956523 Fogarty Advisory Board, 23 May 19956524 Igor Tamm Memorial Symposium, 30 November 19956525 Thomas Merigan Lecture, 23-29 May 19966526 Conference on Immunoglobulins, 2-4 June 19966527 Antibody workshop, 2-4 June 19966528 Simian Virus 40 workshop, 27-28 January 19976529-30 NIAID Principal Investigators' retreat, 20-21 November 19976531 Center for Biologics Evaluation and Research, Vaccines and Related Biological Products Advisory Committee, 19-20 Novebmer 19986532 American Epidemiological Society, 18-19 March 19996533 Memorial Symposium for Robert Huebner, 11 November 19996534 Conference on Vaccine Research, 1-2 May 20006535 NIAID Principal Investigators' workshop, 6-7 November 20006536 NIAID Principal Investigators' workshop, 14-15 November 20026537 RSV 2003 Symposium, 8-11 November 20036538 Trans-NIH/FDA Intramural Biodefense Symposium, 7-8 April 20046539 Rotavirus Symposium, 7-9 July 20056540 RSV Symposium, 15-18 September 2005 Series 7: Lectures and Speeches, 1951-20056541 Control of pediatric viral diseases: past successes and future prospects, undated6542 Untitled ["There seems little reason to doubt that antibody in serum is an important mediator"], c.1950s6543 Hemagluttination with the virus of western equine encephalitis - with Sabin, 30 November 19516544 Hemagglutinins of St. Louis and western equine viruses - isolation, properties, and use for diagnosis and epidemiologic survey, 5 May 19526545 The Hemagglutination test for Japanese encephalitis, a diagnosis and survey tool, 19556546 Untitled ["I'd like to start off by describing in some detail, of course I'll probably be offending some, viruses and some of the tests we use in"], 25 November 19586547 Mycoplasma pneumoniae infections - prospects for live and inactivated vaccines, c.19636548 Infections caused by mycoplasmas, 4 November 19656549 Australia antigen and serum hepatitis, 19706550 Untitled [at International Congress of Microbiology], August 19706551 Parainfluenza virus epidemiology, 3 May 19746552 Untitled ["For approximately the past five years the Laboratory of Infectious Diseases at the NIH in Bethesda has been involved in the study of acute infectious nonbacterial gastroenteritis."], September 19756553 Untitled ["This morning I would like to discuss two areas of study in which we have been involved concerning human reovirus-like agent of infantile gastroenteritis.", 19766554 Chicago talk, 19776555 R. E. Dyer lecture, 30 May 19786556 Medicine for Laymen series lecture, 4 December 19796557 Smadel lecture at Infectious Diseases Society meeting, 26 September 19806558 Saz Immunology Lecture, 9 October 19856559 Successful strategy for selection and characterization of live poliomyelitis virus vaccine strains, 27 October 1986661 Feldman Memorial Lecture, 17-18 March 1987662 FAES lecture, 7 December 1988663-4 Talamo lecture, 4 April 1990665 Children's Hospital National Medical Center, 22 October 1990666 Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations, 7 February 1991667 Careers in virology: a good beginning is usually required for a good ending, 7 or 12 February 1991668 Albert Sabin eulogy, 1993669 Natural history of RSV, 19946610-11 Sabin Lecture, Cold Spring Harbor, September 19956612 Untitled ["sabin.doc"], 19976613 Huebner Symposium lecture, 10 November 19996614 Speech in honor of Brian Murphy, 20036615 R. Walter Schlesinger, M.D. (1913-2003), 5 November 20036616 Tribute to Albertk Kapikian, honored with Albert Sabin Foundation Gold Medal, 16 May 2005 Series 8: Videocassettes, 1985-198767 Wallace P. Rowe Symposium [11 Umatic videocassettes], 12 February 198568 A Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday [9 Umatic, 5 vhs videocassettes], 26 August 198668 Bldg10/ACRF [1 Umatic videocassette], 11 May 1987

    Collection Scope and Content Note

    Correspondence, lab notebooks, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's professional research career at NIAID's Laboratory of Infectious Disease studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses. Research strengths include a nearly comphrehnsive set of lab notebooks documenting the lab's work on Respiratory Syncytial Virus (RSV) and Paramyxoviridae infections and the business of collaborating with various pharmaceutical companies to produce vaccines.

    Series 1, Personal and Biographical (1933-2008), includes correspondence (1950-1957) from research positions Dr. Chanock held before joining NIAID, at the University of Cincinnati and Johns Hopkins, and in the Army in Korea. Dr. Chanock's personal and family life are reflected in correspondence and congratulatory exchanges from colleagues (1933-2008) along with photographs (c.1950s-2005), oral history transcripts (2001-2003), and certificates and awards (1964-2008).

    Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID) (1955-2008) contains incomplete sets of NIAID annual reports (1967-1983), LID annual reports (1966-1997), and LID Board of Scientific Counselor's Reviews (1978-2004). Correspondence (1955-2008) exists in varied orientations: a group arranged alphabetically by correspondent surname spans 1957 to 1979; chronological files are incomplete from 1968 to 1995 and are augmented by informally collected "chronological" files dated 1957-2008; there are also files, arranged alphabetically, by subject (1955-2007). Completing the series is a group of 35mm slide presentations (1961-2005), arranged chronologically, on LID research topics such as mycoplasma and respiratory syncytial virus.

    Series 3, Research (1951-2008) is the largest portion of the collection and has many sections. Lab notebooks (1958-2000) are probably the most comprehensive and valuable part of this series. Arranged by surname of the LID researcher, they provide a day to day picture of research being conducted in the lab. The work of Dr. Chanock, Albert Kapikian, and Wallace P. Rowe are documented here, along with nine other researchers. A smaller set of lab notebooks designated by subject title, such as neuroaminidase, is arranged alphabetically. Research data, (1950-2008), is the least well described part of this series. Often these chronologically arranged folders bear brief titles, leaving only the material's date and context to aid in determining more specifically what studies they may pertain to. Cooperative Research and Development Agreements (CRADA) (1972-2003) with several pharmaceutical companies, notably Lederle and Wyeth, are arranged alphabetically by company name. Research contract reports range in date from 1952 to 1998. All of them after 1957 are contracts with NIAID. Most are arranged by contract number, the bulk of whose numbers are prefaced by "N01" or "PH". Proposals for research contracts which don't correspond to known contracts (1955-2001) are arranged chronologically. Investigational New Drugs (IND) reports (1963-2001) record results, in the form of supplements, of experimental drug testing by NIAID in collaboration with pharmaceutical companies. These are arranged by the Food and Drug Administration's assigned IND number. LID lab research reports (1960-2004) concern only documentation of studies undertaken in the NIAID lab without collaborators. These are arranged chronologically except in the few exceptions when contract numbers are evident.

    Series 4, Patents (1966-2008) which Dr. Chanock co-invented, is arranged numerically by patent number. Related to each is material often in several folders documenting the patent submission and approval process, licensing to pharmaceutical companies, and applications for corresponding foreign patents.

    Series 5, Writings/Reprints (1953-2007) contains an incomplete set of Dr. Chanock's scientific articles, which in their entirety total 653 (1953-2003). Smaller subsections of this series hold eight articles by Dr. Chanock which are not represented on his bibliography (1954-2007); drafts of articles not corresponding with his published work (c.1960s-c.2007); and untitled drafts and writing fragments (c.1955-c.2007). Reprints are arranged by number assigned in Dr. Chanock's bibliography. The other sections are chronological.

    Series 6, Meetings (1954-2005) contains programs, proceedings, notes, and other related information collected by Dr. Chanock when he attended national and international health conferences focusing on virology. He regularly attended meetings held by the American Society for Clinical Investigation, World Health Organization, American Epidemiological Society, and American Society for Microbiology. The series is arranged chronologically.

    Series 7, Lectures and Speeches (1951-2005) are arranged chronologically. While a number of the earlier speeches lack identification as to where or when they were delivered, most after 1970 were lectures given at conferences or on honorary occasions.

    Series 8, Videocassettes (1985-1987) mostly cover two subjects: the February 12, 1985 Wallace P. Rowe Symposium, and the August 26, 1986 Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday.

    Contents List
    Box | Folder Title
     
    Series 1: Personal and Biographical, 1933-2008 [series]:
    1 1
    Biographical sketches, 1993-1998
    1 2
    Scrapbook, 1950-1973
    1 3-6
    CVs and bibliography, 1987-2004
    1 7
    High school essays, 1940-1941
    1 8
    University of Chicago - correspondence, 1942-1949
    1 9
    University of Chicago Medical and Biological Sciences Alumni Association - reunion class of 1947 - dinner menu and yearbook, 1997
    1 10-12
    University of Chicago - course notes, lab procedures, dietary formulations, 1948-1950
    69 1
    Sydenham Hospital patient records, 1948 [RESTRICTED PHI POLICY]
    1 13
    Medical license, 1976-1994
    1 14
    Army discharge, 1946
    1 15-22
    U.S. Army service in Korea - correspondence, orders, data, 1949-1955
    69 3
    U.S. Army - Korea - Q fever and scrub typhus, 1953 [RESTRICTED PHI POLICY]
    1 23-26
    University of Cincinnati College of Medicine fellow - correspondence, reports, 1950-1952
    1 27
    Children's Hospital Research Foundation - correspondence, 1955-1956
    69 4
    University of Cincinnati College of Medicine, 1955 [RESTRICTED PHI POLICY]
    1 28-30
    Johns Hopkins - correspondence, laboratory manual, notes, 1956-1957
    1 31-34
    PHS Commissioned Officer - orders, correspondence, identification, retirement, 1957-1988
    1 35-37
    National Institute of Allergies and Infectious Diseases Oral History Interview - conducted by Peggy Dillon, 2001-2003
    1 38
    Retirement guestbook, c.2008
     
    Family Correspondence, 1933-1995 [subseries]:
    1 39
    From Robert to his family, 1933
    1 40
    From Robert to Beth Chanock, 1948-1955
    1 41
    Notes, c.1950s
    1 42
    Well wishes on pericarditis, 1967
    2 1
    Family and friends, 1968-1995
    2 2
    Congratulations on birth of grandson, 1983
    2 3
    Chanock, Foster Osgood, 1975-1980
    2 4
    Chanock, Frances E., 1995
    2 5
    Chanock, Stephen J., 1971-1989
     
    Awards and Honors, 1945-2008 [subseries]:
    2 6
    Various certificates, 1945-2008
    2 7
    E. Mead Johnson Award for Research in Pediatrics - congratulations and correspondence, 27 October 1964
    2 8
    Kimble Methodology Award - letters of congratulations and correspondence, 31 October 1966
    2 9
    Infectious Diseases Society of America Squibb Award - congratulations, correspondence, and acceptance speech, 25 October 1969
    2 10
    DHEW Distinguished Service Medal - correspondence, photographs, and ceremony program, 15 April 1971
    2 11
    Gorgas Medal - announcement and clipping, 11 December 1972
    2 12
    Election to National Academy of Sciences - letters of congratulations, 1973
    2 13
    Howard Taylor Ricketts Award - announcement, congratulations, event program, lecture transcript, 14 May 1973
    2 14
    Award for Distinguished Achievement - announcement, 1976
    2 15
    University of Chicago - honorary doctorate - announcement, photographs, and convocation program, 14 November 1977
    2 16-17
    Robert Koch Stiftung Award - correspondence, letters of congratulations, ceremony program, photographs, lecture transcript, 7 December 1981
    2 18-23
    ICN International Prize in Virology - announcement, correspondence, letters of congratulations, ceremony program, photographs, 7 February 1991
    2 24
    Presidential Meritorious Executive Rank Award, 1993
    2 25-26
    Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research - announcement, letters of congratulations, ceremony program, and clippings, 7 December 1993
    2 27
    Albert B. Sabin Gold Medal Award - letters of congratulations, ceremony program, lecture transcript, and clippings, 14 September 1995
    2 28
    American College of Physicians Award for Outstanding Work in Science as Related to Medicine - correspondence, May 2008
     
    Photographs, c.1950s-2005 [subseries]:
    2 29
    Aboard the 'Independence', c.1950s
    2 30
    Dr. Chanock's friends and colleagues, c.1960s-2000s
    2 31-33
    Dr. Chanock - with family, in groups, in PHS uniform, at conferences, in laboratory, 1988-1998, undated
    2 34
    A celebration of the career of Dr. Robert M. Chanock, Laboratory of Infectious Diseases, NIAID, NIH, 21 October 2005
     
    Clippings, 1954-2008 [subseries]:
    2 35-37
    General, 1958-2008
    3 1
    Obituaries of colleagues, 1995-1998
    3 2
    re Influenza, 1947-1998
    3 3
    Virus discoveries, 1954-1980
    Born Digital
    Archive-It web archive, top results for "Robert Chanock" Google search conducted by HMD staff, 2018 [view online]
     
    Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID), 1955-2008 [series]:
    3 4-14
    NIAID Annual Reports, 1967-1972
    4 1-14
    NIAID Annual Reports (cont'd), 1973-1980
    5 1-5
    NIAID Annual Reports (cont'd), 1980-1983
    5 6-13
    LID Board of Scientific Counselors Review, 1978, 1981, 1984, 1987, 1992, 1996
    6 1-11
    LID Board of Scientific Counselors Review (cont'd), 1996, 2000, 2003, 2004
    6 12-23
    LID Annual Reports [3.5 computer disks], 1966-1970; 1972-1973, 1976, 1982, 1984, 1985, 1987
    7 1-14
    LID Annual Reports (cont'd), 1987-1996
    8 1-2
    LID Annual Reports (cont'd), 1996-1997
    8 3-35
    Calendar - Dr. Chanock's, 1971-2006
     
    Correspondence, 1955-2008 [subseries]:
    8 36-50
    Alphabetical by correspondent - A-H, 1957-1968
    9 1-19
    Alphabetical by correspondent - H-W, 1957-1968
    9 20-25
    Alphabetical by correspondent - A-L, 1969-1975
    10 1-6
    Alphabetical by correspondent - M-Z, 1969-1975
    10 7-24
    Alphabetical by correspondent - A-T, 1975-1996
    10 25-27
    Alphabetical by correspondent - A-Z, 1978-1979
    10 28
    Becker, Walter B., 1963-1971
    10 29
    Brown, Fred, 1989-1992
    10 30
    Children's Hospital, Philadelphia - Dr. Lief, 1964-1966
    10 31
    Croup agent, 1955-1958
    10 32
    Fenner, Frank, 1978-1997
    10 33
    Roizman, Bernard, 1974-1988
    10 34
    Siim, J. Christian, 1979-1991
    10 35
    Stuart-Harris, Charles, 1977-1983
    10 36
    Syrucek, Lubomir, 1965-1972
    10 37
    Walter Reed Army Medical Center, 1962-1969
    10 38
    Wyeth Laboratories, 1964-1969
    10 39-41
    Chronological Files, 1968, 1971-1972
    11 1-21
    Chronological Files, 1973-1981, 1984-1986, 1989-1993, 1995
    11 22-44
    Chronological miscellaneous correspondence, undated, 1957-1980
    12 1-28
    Chronological miscellaneous correspondence (cont'd), 1981-2008
     
    Correspondence of Harry Greenberg and Anthony Kalica, 1976-1983 [subseries]:
    12 29
    Greenberg, Harry correspondence - A-Z by correspondent name, 1976-1983
    12 30
    Kalica, Anthony correspondence - A-Z by correspondent name, 1976-1982
    13 1
    Kalica, Anthony correspondence - A-Z by correspondent name (cont'd), 1976-1982
     
    Subjects, 1955-2007 [subseries]:
    13 2-5
    1918 Flu 2005 Avian Flu, 2002-2006
    13 6
    4 New Breast Cancer Genes / DNA Variations for 7 Diseases, 2007
    13 7-8
    Acambis, 1999-2007
    13 9
    Adenovirus and AAV, 1964-2001
    13 10
    Adjuvants for influenza virus vaccines, including use for H5N1 if needed, 2006
    13 11
    Agracetus [photocopy of 1947 article], undated
    13 12-13
    Albert B. Sabin Vaccine Foundation, Inc., 1991-1994
    13 14-15
    Anthrax, 1999-2004
    13 16
    Anthrax incidents, hoaxes and threats, 1999
    13 17
    Armed Forces Epidemiological Board (AFEB) - 50th year anniversary, 28 June 1990
    13 18-19
    AFEB Commission on Acute Respiratory Diseases - annual reports, 1969, 2001
    13 20
    AFEB Commission on Influenza - annual report, 1971
    13 21
    Australian National University - annual reports, 1961-1967
    13 22-23
    Avian flu, 2002-2007
    13 24
    Biodefense NIAID, 2002
    13 25
    Bioshield 5105, 2005
    13 26
    Bioterrorist activities - Peter Jahrling, Ph.D. [35mm slides], 29 January 1999
    13 27
    Biowarfare, 1988-1994
    13 28
    Byrne, Robert J., D.V.M. - Deputy Director, Experimental Applications Branch, NIAID, 1979-1980
    13 29
    Chiefs of NIAID [photographs], 2001
    14 1
    Choppin, Purnell, c.1985
    14 2
    Cold Spring Harbor correspondence, 1986
    14 3
    Conflict of interest issues, 2005
    14 4
    Consultancies - Molecular Vaccines, Inc., and Medimmune, 1988-2002
    14 5
    Dangers of mutants, 1977
    14 6
    Dengue - Jo Blaney, 28 November 2007
    14 7
    Dengue vaccine, c.1989
    14 8
    Inter-Divisional Vaccine Working Group, 17 September 1993
    14 9
    Edelman memos and correspondence, 1976-1988
    14 10
    Ethics - L.A. Times, September-October 2004
    14 11
    Executive office NIAID, 1985-1988
    14 12
    Fauci, Dr. Anthony - Director NIAID, 1985-1987
    14 13-15
    Food and Drug Administration (FDA) - Panel on Review of Viral Vaccines and Rickettsial Vaccines, 1975
    14 16
    Freezer repository - inventory contents, 1992
    14 17
    Gallin, Dr. John - Director, Intramural Research Program, NIAID, 1985-1988
     
    Goldberg II [subseries]:

    Articles sent to Dr. Chanock by journalist Billie Goldberg organized thematically.

    14 18
    Antivirals, 2005
    14 19
    Cancer, 2005
    14 20
    Dengue, 2005
    14 21
    DNA vaccines, 2005
    14 22
    Ebola and Marburg vaccines, 2005
    14 23
    HIV SIV, 2005
    14 24
    Human melanoma virus, 2005
    14 25
    Immunology, 2005
    14 26
    Nobel, 2005
    14 27
    RNAi, 2005
    14 28
    Shingles, 2005
    14 29
    Aviflu, 2006
    14 30
    Biodefense tick borne encephalitis virus, 2006
    14 31
    HIV vaccine, 2006
    14 32
    Important role of inflammation in cardiovascular disease, 2006
    14 33
    Kaposi sarcoma virus receptor, 2006
    14 34
    Old viruses resurrected inhuman DNA, 2006
    14 35
    Osteoporosis protein diabetes genes, 2006
    14 36
    Polio-Weimmer, 2006
    14 37
    Prostate cancer Rx therapy, 2006
    14 38
    RNAi clinical, 2006
    14 39
    Max Theiler 1951, 2006
    14 40
    Vertex HCV, 2006
    14 41
    Vioxx Merck, 2006
    14 42
    West Nile transplant patients, 2006
    14 43-44
    Hartley, Janet, 1981-1994
    14 45
    House hearings on influenza vaccine, August 1972
    14 46
    Huebner, Robert, 1969-2002
    15 1
    Huebner, Robert (cont'd), 1969-2002
    15 2
    Huebner celebration, 11 November 1999
    15 3
    Hybridon - contract and approval, 1994-1996
    15 4
    ICN Pharmaceuticals, 1990-1991
    15 5
    Infectious Disease Society of America, 1990
    15 6
    Infu H5N1 DOD/NIAID, 2006-2007
    15 7
    Interpretation of serologic reactions in virology - DHEW, c.1965
    15 8-9
    Intracel, 2000-2001
    15 10
    Intramural Research Program, 1985-1987
    15 11
    Johns Hopkins Society of Scholars, 1999
    15 12
    Kapikian, Albert Z. [photographs], 1984
    15 13
    Krause, Richard M. - Director, NIAID, 1979-1981
    15 14
    Krause, Richard M. (cont'd), 24 March 1995
    15 15
    Laboratory methods in the diagnosis of viral exanthems - DHEW, c.1965
    15 16
    Laboratory of Viral Diseases - annual report, 1969
    15 17
    Laboratory of Infectious Diseases - history [35mm slides], 1992
    15 18
    Laboratory techniques in virology - DHEW, c.1965
    15 19
    Mattheis, Martha - Infectious Disease Branch, 1979-1984
     
    MedImmune [subseries]:
    15 20
    General, 1998-2005
    15 21-25
    General (cont'd), 1998-2005
    15 26
    Adverse publicity, 1998
    15 27
    Biological materials license agreement, 1996
    15 28-38
    Meetings, 1989-2002
    16 1-4
    Meetings (cont'd), 1989-2002
    16 5
    Sales of Synagis, January-March 2000
    16 6
    Molecular Vaccines, Inc., 1988-1989
    16 7
    Monoclonal abs, RSV and otherwise, 1990-1994
    16 8-14
    Morris, Anthony, 1973-1978
    16 15-16
    Mycoplasma pneumonia and others, 1961-2002
    16 17-27
    National Academy of Sciences - Committee on International Security and Arms Control (CISAC), 1988-1997
    17 1-8
    National Academy of Sciences - Committee on International Security and Arms Control (CISAC) (cont'd), 1988-1997
    17 9
    National Academy of Sciences - Sabin, memoirs Rowe, 1998
    17 10
    National Cancer Institute - Frederick Cancer Research Facility Advisory Committee - meeting, 13 February 1987
    17 11
    NIAID Animal Care Committee, 1973-1980
    17 12
    NIAID Biodefense Research Agenda for Category B and C Priority Pathogens - progress report, 2004
    17 13-14
    NIAID Blue Ribbon Panel on Terrorism and its Implications for Biomedical Research, 2002
    17 15-16
    NIAID Clinical Research Subpanel, 1969-1980
    18 1
    NIAID Clinical Research Subpanel (cont'd)
    18 2
    NIAID Committee for Vaccine Development - correspondence, 1962-1967
    18 3
    NIAID Extramural Activities - report, 1968
    18 4-6
    NIAID Intramural Research Program - reports, 1968-1972
    18 7
    NIAID Laboratory Chiefs - meeting minutes, 2002-2005
    18 8
    NIAID Laboratory of Biology of Viruses - annual report, 1968
    18 9
    New York City Department of Health - laboratory analysis of 1957-1958 influenza outbreak in New York City, 1959
    18 10-11
    Pandemic avian flu - Secretary Leavitto's response for greater vaccine production from pharmaceutical manufacturers, 2006
    18 12
    Pandemic flu preparedness, 2001
    18 13
    Papilloma viruses, c.2000
    18 14-15
    Parainfluenza virus, 1998
    18 16
    Parainfluenza virus / glioma, 2004-2005
    18 17
    Pletnev 5 yr plan, 2004
    18 18
    Pneumonia, 1979
    18 19
    RSV and PIV3 high risk persons: RSV LID, 1991-1992
    18 20-21
    RSV pathogenesis acute and COPD (II), 1993
    18 22-26
    Rowe and Huebner [photographs], 1982-1998
    18 27
    Royal Danish academy of Sciences and letters - elected as foreign member, 1980
    18 28-29
    Russian TBEV collaboration, 2002
    18 30-33
    Sabin, Dr. Albert [photographs], 1964-2006
    19 1-7
    Sabin, Dr. Albert (cont'd), 1964-2006
    19 8
    Sabin poliovaccine [35mm slides], c.1986
    19 9
    Sabin poliovirus vaccine clinical field trials - final report, 1961
    19 10
    Sabin/Schlesinger dengue, 2003
    19 11
    Scripps Research Institute, 1987-1996
    19 12
    Seasonal and pandemic influenza, 2007
    19 13
    Sell, Kenneth W. - Scientific Director, NIAID, 1978-1984
    19 14
    Small pox, 2001-2006
    19 15
    Smorodintsev adenovirus vaccine, 1969
    19 16
    Society for Pediatric Research, 1993
    19 17
    Sugata, Fumihiko, 1993
    19 18
    Synagis, 1999-2001
    19 19
    Synergistic effect when two disparate mabs are used, 2002-2006
    19 20
    Tyrrell, D. A., Jr., 1970-1991
    19 21
    U.S. Public Health Service - technical report on Salk poliomyelitis vaccine, 1955
    19 22
    University of British Columbia, Dept. of Microbiology, Div. of Medical Microbiology - annual report, 1971
    19 23
    University of Maryland - prison studies hearing, 3 September 1975
     
    Vaccine, 1958-2006 [subseries]:
    19 24
    Adenovirus vaccine program - business case analysis, c.2006
    19 25
    Vaccine development at the Laboratory of Infectious Diseases, c.2000
    19 26
    Current status of vaccines for prevention of respiratory syncytial virus infection in infants and children - Peter Wright, 2003
    19 27
    Licensed viral vaccines (U.S.A.), 1988
    19 28-29
    Rotavirus vaccines, 2000-2006
    19 30
    Virology Section - report, 1970
    19 31
    West Nile and Dengue, 2003
    19 32
    World Health Organization (WHO) - viral disease reports, 1958-1971
    19 33
    WHO Expert Advisory Panel on Virus Diseases, 1997
     
    Presentations on 35mm Slides, 1961-2005 [subseries]:
    19 34
    Influenza Dearborn TS1[E], undated
    19 35
    Influenza TS1, undated
    19 36-40
    Mycoplasma, undated
    20 1-2
    PI Mpn epidem., undated
    20 3
    Poly IC study Knopp, undated
    20 4
    Respiratory Syncitial, undated
    20 5
    Respiratory Syncitial Coates, undated
    20 6
    Smith and Chanock Eaton vol, undated
    20 7
    Mycoplasma, 1961
    20 8
    Pneumonia, 1961
    20 9
    Respiratory Syncytial Mpn, 1961
    20 10
    Adeno caps PI, 1964
    20 11-12
    Mycoplasma, c.1965
    20 13
    Respiratory Syncytial and Para, c.1966
    20 14
    IOM priorities and Respiratory Syncytial Virus, 1966
    20 15
    Mycoplasma, c.1967
    20 16
    Mycoplasma Boston, 1967
    20 17
    Importance viruses and Mpn respiratory disease, 1968
    20 18
    Respiratory Syncytial temperature sensitive, 1968
    20 19
    Mycoplasma, 1969
    20 20
    Mycoplasma pneumoniae ASM, 1970
    20 21
    Mycoplasma, pneumonia, pap, 1970
    20 22
    PAHO, December 1970
    20 23
    Flu (temperature sensitive), 1971
    20 24
    Mycoplasma, 1971
    20 25
    Respiratory Syncytial Virus, 1971
    20 26
    Mycoplasma NY Acad., January 1973
    20 27
    Respiratory Syncytial, 1973
    20 28
    Animal rights, c.1979
    20 29
    Rotavirus, dengue, vaccines, etc., 1980-1981
    20 30
    Long-term goals and strategy of LID research / Sabin polio vaccine, 1986-1988
    20 31
    RSV, dengue, etc., c.1989
    20 32
    Respiratory Syncytial, 1989
    20 33
    Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries, 1990
    20 34
    Respiratory Syncytial Virus vaccines, 1990
    20 35
    Rotavirus, 1990
    20 36
    Respiratory Syncytial Virus mabs and fabs, 1990-1995
    20 37
    Respiratory Syncytial Virus, 1991
    20 38
    Respiratory Syncytial Virus, 1992-1993
    20 39
    Respiratory Syncytial Virus (cont'd), 1992-1993
    20 40
    St. Lucia - history of respiratory, December 2000
    20 41
    Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens, 2004
    20 42
    Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development, 2005
     
    Series 3: Lab Research, 1951-2008 [series]:
     
    Lab Notebooks by researcher, 1958-2000 [subseries]:
    21 1-2
    Abinanti, Francis R., 1958-1964
    21 3-19
    Chanock, Robert M., 1958-2000
    22 1-19
    Chanock, Robert M. (cont'd), 1958-2000
    23 1-19
    Chanock, Robert M. (cont'd), 1958-2000
    24 1-4
    Chanock, Robert M. (cont'd), 1958-2000
    24 5-8
    Cook, M. Katherine, 1960-1975
    24 9
    Dans, Peter E., 1966-1967
    24 10
    Forsyth, Ben R., 1965-1966
    24 11-18
    Hoggan, M. David, 1972-1985
    24 19
    Johnson, Karl M., 1959-1962
    25 1-3
    Johnson, Karl M. (cont'd), 1959-1962
    25 4-8
    Kapikian, Albert Z., 1977-1981
    25 9-10
    Lewis, Marianne, 1972-1984
    25 11-17
    Mufson, Maurice A., 1962-1965
    25 18-19
    Rowe, Wallace P., 1958-1972
    26 1-19
    Rowe, Wallace P. (cont'd), 1958-1972
    27 1-16
    Rowe, Wallace P. (cont'd), 1958-1972
     
    Lab Notebooks by Subject, 1954-1994 [subseries]:
    27 17
    CF Antigens, 1954-1975
    27 18
    Miscellaneous Virus, 1957
    27 19
    Neuraminidase, 1974-1993
    28 1-8
    Neuraminidase (cont'd), 1974-1993
    28 9
    Radioactive Materials, 1971-1974
    28 10-16
    Viral Reagents, 1962-1994
     
    Research Data, 1950-2008 [subseries]:
    28 17-19
    Miscellaneous/Unidentified Studies, undated
    29 1-7
    Miscellaneous/Unidentified Studies (cont'd), 1950-2005
    29 8
    Japanese B encephalitis, 1951-1954
    29 9
    Lab studies on adenovirus, pneumonia or bronchiolites, 1952-1956
    29 10
    Avian Japanese B encephalitis, 1953-1955
    29 11
    Transplacental transmission polio virus, 1954-1955
    29 12
    Polio chick embryo, 1955
    29 13
    Yale - Monkey kidney trypsinization techniques Ph colon test, 1955-1956
    29 14
    Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated, 1956
    29 15
    Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant, 1956
    29 16
    Serology, 1956-1957
    69 9
    1 RSV collation, 1956-1957 [RESTRICTED PHI POLICY]
    29 17
    Croup, 1956-1959
    29 18
    Pap virus, 1958-1959
    69 11
    Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries, 1959-1960 [RESTRICTED PHI POLICY]
    29 19
    Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island, 1959-1961
    29 20
    #2 neutralization tests #19, 1959-1998
    29 21
    Immunization, 1961-1962
    69 14-15
    RS vaccine study, 1962-1975 [RESTRICTED PHI POLICY]
    29 22
    Contribution of adenoviruses to respiratory tract illness among children, 1963
    29 23
    Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4, 1963
    29 24-25
    Lots of vaccine - Wyeth, 1963-1968
    29 26-27
    Mycoplasma, 1963-1992
    29 28
    Ludwig adeno capsule, 1964
    29 29
    Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island, 1964-1965
    30 1
    Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island, 1965-1966
    30 2
    Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2, 1965-1970
    69 18
    Children's Hospital contract reports, 1965-1981 [RESTRICTED PHI POLICY]
    30 3
    Drug protocols - Wyeth, 1966
    30 4
    Respir. Viruses and mycoplasmas clinical: adeno field trials other, 1966-1967
    69 17
    RS vaccine study, 1967 [RESTRICTED PHI POLICY]
    30 5
    Experimental rubella vaccine lot 12-6/6A, 1967
    30 6
    Myxovirus recovery from respiratory tract illness - summary tables, 1967
    30 7
    Camargo, Ena - RSV - paraflu III plaque, 1967-1972
    30 8-13
    RS vaccine - Children's Hospital of D.C., 1967-1979
    30 14-16
    Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth, 1968-69
    30 20
    RS #3 challenge of para 1 new, November 1970
    30 17
    RS ts 1 mutant - Jessup, 30 December 1969
    30 18
    Clinical research protocols, 1969-1978
    30 19
    RS volunteer - wild type challenge of ts1 vaccinees, 13 February 1970
    30 21
    DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2, 1970-1972
    30 22
    Antibody response to m. pneumoniae vaccine, 1971
    30 23
    RSV clinical summary - Children's Hospital, 1971
    30 24
    Virus-associated immunopathology animal models and implications for human diseases, c.1972
    30 25
    RSV primates: to RS in children, c.1972-1973
    69 23
    Children's Hospital - nasal washings, 1972-1974 [RESTRICTED PHI POLICY]
    30 26
    Lab reports, 1973
    30 27
    Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C., 1973
    30 28
    Clinical observation of infants/children receiving RS-A2, ts-1 mutant, 1973
    30 29
    Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory, 1974
    30 30
    Safety test protocol - A/Georgia/101/74 clone 1B, 1974
    30 31
    RS vaccine summaries - Children's Hospital, 1974-1975
    31 1
    RSV primates: bovine RSV in cotton rats, owl monkeys and chimps, 1974-1993
    31 2
    Swine influenza - Burroughs Wellcome Research Labs, 1975-1979
    31 3
    Camargo, Ena - RSV, 1975-1980
    31 4
    Huebner tumorigenicity TS-1-E (Morris), 1976
    31 5
    Status of two dose trials, 1976
    31 6
    Safety test - parainfluenza virus type 3, strain #22311 (lot F-367), 1976
    31 7
    RSV primates: genetic stability - stress tests RS, 1976-1989
    31 8
    Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs, 1977
    31 9
    Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant, 1977-1979
    31 10
    RSV primates II, 1977-1991
    31 11
    Attenuated influenza vaccines, 1981
    31 12
    Nasal washings - Children's Hospital, 1981
    31 13
    RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps, 1981
    31 14
    RSV primates: cotton rat RS, 1981
    31 15
    RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps, 1982
    31 16
    RSV primates, 1982-1993
    31 17
    Research labs - Merck Sharp and Dohme, 1983-1991
    31 18
    SV40, 1983-2001
    31 19-20
    Production protocols - Wyeth, 1985
    31 21
    RSV hr mutants in primates ts in primates: primates studies RSV, 1986-1990
    31 22
    Immunization: flavi and alpha viruses, 1988
    31 23
    Prophylactic effect antibodies, 18 October 1988
    31 24
    MF59 Chiron, 1989-2006
    31 25
    RSV vaccine testing, 1989-2006
    31 26
    Fourth NIH rotavirus vaccine workshop, 5-6 November 1990
    31 27
    RSV ICN Krugman, 1991-1993
    31 28
    Flavivirus vaccine research - Walter Reed-NIAID, 1991-1994
    31 29-30
    RSV human fob monoclones, December 1991-February 1995
    31 31
    CA influenza virus - Wyeth, 1992-1993
    31 32
    RSV - Repligen, 1993
    31 33
    Fab 19 MARM, 1993-1995
    31 34
    RSV human FABS, 5 February 1995
    31 35-36
    AGMK cells, karyotype, tumor tests, patent, 1994-2000
    32 1-3
    Bovine RV (4x) clinical trial, 1997
    32 4
    U.S.-Russian collaboration final report, 1997
    32 5-7
    TBEV LGT, 1998-2000
    32 8-9
    TBEV II and West Nile, 2000
    32 10
    History of discovery and development of successful interventions, 2000
    32 11
    West Nile virus, 2000-2006
    32 12
    Periodic dengue, West Nile, TBEV meetings, 2001
    32 13-14
    Dengue vaccine part II, 2001-2007
    33 13
    Dengue virus and West Nile virus, 2008
    32 15
    Dengue virus vaccine development, 2002
    33 1
    TBEV and Langat II, 2002
    33 2
    Dengue virus vaccine data, 2003
    33 3
    Restoration of live adenoviruses vaccine in DOD, 2003-2005
    33 4-6
    Negative SV40, 2004
    33 7-8
    Positive SV40, 2004
    33 9
    Dengue virus vaccine development, 2004
    33 10
    Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity, 2005
    33 11
    Dengue candidates, August 2006
    33 12
    Den langat, 2006
     
    LID Lab Research Reports, 1960-2004 [subseries]:
    33 14-27
    Clinical research projects, 1960-1982
    33 28
    NIAID ad hoc contract review, 1973
    33 29
    Experimental immunoprophylaxis against respiratory syncytial virus infections in primates, undated
    33 30
    Experimental infection of primates with respiratory syncytial virus, undated
    33 31
    Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus, undated
    33 32
    Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants, undated
    33 33
    RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research, 1968
    33 34
    Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections, 1969
    33 35
    Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age, 1969
    33 36
    Serum complement in acute bronchiolitis, 1969
    33 37
    Pediatric adenovirus vaccine evaluations, 1971
    33 38
    Fort Detrick reports, 1972-1977
    34 1
    Chanock scientific studies, 1973-1992
    34 2
    Transferring viruses to NIAID, 1997-1998
    34 3
    Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section, c.2000
    34 4-5
    Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section, 2000-2001
    34 6
    Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers, 2001
    34 7
    Projected schedule for WNV/DEN4 chimera studies, 2001
    34 8
    New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus, 2003
    34 9
    The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section, 2004
    34 10
    In vitro models of paramyxovirus infection, 2004
    34 11
    New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section, 2004
    34 12
    NIAID 69-A - Study of non-bacterial respiratory disease A) children, 1966-1969
    34 13
    NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis, 1966
    34 14
    NIAID 69-C - The etiology of acute respiratory disease in civilian adults, 1965
    34 15
    NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines, 1966
    34 16
    NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness, 1966
    34 17
    NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin, 1966
    34 18
    NIAID 70-C - Basic studies on mycoplasma, 1966
    34 19
    NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO), 1966
    34 20
    NIAID 70-D - Laboratory studies of viral hepatitis agents, 1966
    34 21
    NIAID 70-E - Biological and biophysical studies of rhinoviruses, 1966-1969
    34 22
    NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers, 1969
     
    Investigational New Drugs (IND), 1963-2001 [subseries]:
    34 23
    Unnumbered - Attenuated quadrivalent human-bovine (UK) rotavirus reassortant vaccine - original submission, 1995
    34 24
    Unnumbered - Wild-type and attenuated respiratory syncytial viruses; subgroup B, 1993
    34 25
    IND #24 - Parainfluenza type 3 vaccine - suppl. 1-4, 1963-1967
    34 26-31
    IND #71 - Live adenovirus type 4 enteric vaccine - suppl. 31-50, 1967-1972
    34 32-35
    IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24, 1964-1973
    35 1-2
    IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24 (cont'd), 1964-1973
    35 3
    IND #385 - Monovalent adenovirus type 2 soluble antigen vaccine, aqueous or alum absorbed - suppl. 1, 4-6, 1969-1971
    35 4
    IND #386 - Live, attenuated rubella virus vaccine strain HPV-79-RK 7, lot 31764 - suppl. 2-3, 1969
    35 5
    IND #401 - Meningococcal group C vaccine - suppl. 1-36, 1969-1973
    35 6-7
    IND #419 - Complexed polyinosinic and polycytidylic acids - suppl. 1-13, 1969-1970
    35 8-9
    IND #421 - Parainfluenza 3 challenge pool (attenuated?) - suppl. 1-23, 1969-1973
    35 10
    IND #437 - Pneumococcal polysaccharide vaccines, 1970-1972
    35 11
    IND #450 - Vaccinia virus vaccine -suppl. 7, 1971
    35 12
    IND #582 - H. Influenzae type b PRP vaccine - suppl. 10, 188, 1972-1987
    35 13-20
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399, 1972-1995
    36 1-17
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
    37 1-18
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
    38 1-18
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
    39 1-18
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
    40 1-18
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
    41 1-3
    IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd), 1972-1995
    41 4-5
    IND #734 - TS mutants of mycoplasma pneumoniae - suppl. 1-1C (inactive), 1974-1977
    41 6
    IND #735 - Inactivated monovalent influenza B virus vaccine, 1973
    41 7-8
    IND #825 - Inactivated influenza A virus vaccines subunit - suppl. 1-30, 1974-1980
    41 9
    IND #839 - Poly I; poly C: poly-l-lysine - suppl. 1, 1974
    41 10
    IND #1044 - Live parainfluenza virus vaccines types 1, 2, and 3, placebo - suppl. 1-8 (inactive), 1975-1978
    41 11-19
    IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51, 1976-1980
    42 1-6
    IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51 (cont'd), 1976-1980
    42 7
    IND #1287 - Adenovirus subunit vaccines - suppl. 1-11, 1978-1982
    42 8-17
    IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118, 1978-1990
    43 1-17
    IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118 (cont'd), 1978-1990
    43 18
    IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37, 1979-1993
    44 1-5
    IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37 (cont'd), 1979-1993
    44 6
    IND #1462 - Varicella virus vaccine - suppl. 123, 1987
    44 7-20
    IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139, 1980-1998
    45 1-15
    IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139 (cont'd), 1980-1998
    45 16
    IND #1808 - E. coli CFA/II pili vaccine oral - suppl. 4, 1985
    45 17
    IND #1914 - Interferons - suppl. 9-10, 1985
    45 18
    IND #2000 - Vi capsular antigen - suppl. 4, 1985
    45 19-21
    IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63, 1988-1995
    46 1-7
    IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63 (cont'd), 1988-1995
    46 8-10
    IND #2858 - Bovine parainfluenza virus type 3 - suppl. 1-30, 1988-1994
    46 11-14
    IND #4006 - Rhesus rotavirus vaccines, live, (tetravalent, serotypes 1, 2, 3, and 4) oral - suppl. 1-25, 1988-1998
    46 15-19
    IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58, 1993-2000
    47 1-5
    IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58 (cont'd), 1993-2000
    47 6-9
    IND #4981 - Respiratory syncytial virus subgroup B (strain 14617, vero 1 cells) wild type and attenuated live vaccines - suppl. 1-33, 1993-2000
    47 10
    IND #7762 - Respiratory syncytial virus, live, attenuated vaccine and purified fusion protein with alum - suppl. 1-6, 8-9, 1998-2001
     
    Research Contracts, 1952-2001 [subseries]:
     
    Proposals, 1955-2001 [subseries]:
    47 11
    Unidentified, undated
    47 12
    Etiology of viral diarrheas - part III, undated
    47 13
    To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg, 1955
    47 14
    Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., c.1964
    47 15
    The isolation of viruses and viral subunits, 1964
    47 16
    Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures, c.1965
    47 17
    Studies on adenovirus vaccines, c.1965
    47 18
    Biochemical and immunologic investigations of neisseria meningitidis, 1965
    47 19
    Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae, 1965
    47 20
    To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., 1965
    47 21
    Concentration of human hepatitis virus (supplement to NIAID Support of Man program), 1966
    47 22
    Proposed vaccine studies, Kansas City, 1966
    47 23
    Respiratory virus vaccines, 1967
    47 24
    Tests in infants and children for antigenicity and effectiveness of inactivated vaccines, 1967
    47 25
    X-ray crystal structure of adenovirus coat protein, 1969
    47 26
    Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971
    47 27
    Studies on hemophilus influenzae b vaccine, c.1972
    47 28
    Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization, 1974
    47 29
    Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells, 1975
    47 30
    Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection, 1975
    47 31
    Protective efficacy of langat virus vaccines in mice - animal study proposal, 1997
    47 32
    Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal, 1999
    47 33
    Evaluation of chimeric TBEV/DEN4 virus vaccines in mice, 2001
    47 34
    Immunogenicity and protective efficacy of langat virus vaccines in mice, 2001
     
    Reports, 1952-1998 [subseries]:
    47 35-39
    National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati, 1952-1956
    47 40
    Vaccine development program commitments, 1965
    47 41
    Respiratory vaccine development, 1966
    47 42
    Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory, 1967
    47 43
    NIAID Molecular Anatomy Program, 1967
    47 44
    Evaluation of a live type 4 adenovirus vaccine, 1967-1968
    47 45
    Acute infectious nonbacterial gastroenteritis, 1973
    47 46
    103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies, 1964-1965
    47 47
    6-61-03-032 - Studies on virus and rickettsial diseases, 1953
    47 48
    263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions, 1981
    47 49
    263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions, 1981
    47 50
    3A014501B71Q - Communicable diseases - immunology, c.1966
    47 51
    DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines, 1963
    47 52
    DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus, 1965
    47 53
    DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections, 1965
    47 54
    DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus, 1967
    47 55
    DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus, 1971
    47 56
    DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus, 1971
    47 57
    M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits, 1972
    48 1
    NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines, 1970
    48 2
    NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines, 1970
    48 3
    NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1969
    48 4
    NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines, 1971
    48 5-6
    NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971, 1973
    48 7
    N01-AI-01528 - New viruses in relation to clinical diseases, 1968-1972
    48 8-9
    N01-AI-02638 - Operation of a virus vaccine production laboratory, 1980-1981, 1983-1987
    48 10
    N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals, 1981
    48 11-13
    N01-AI-05057 - University of Puerto Rico, 1991-1992
    48 14-15
    N01-AI-05067 - Care and housing of AIDS research animals, 1990-1991
    48 16
    N01-AI-17757 - Children's Hospital, 1980-1981
    48 17-19
    N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults, 1972-1989
    48 20
    N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains, 1974
    48 21
    N01-AI-22508 - Clinical evaluation of influenza virus vaccines, 1974
    48 22
    N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . ., 1993-1994
    49 1-2
    N01-AI-32521 - Operation of a virus laboratory in support of LID, 1974-1990
    49 3-4
    N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity, 1978
    49 5
    N01-AI-42528 - Influenza research center, 1979
    49 6
    N01-AI-52565, 1985-1987
    49 7-8
    N01-AI-72535 - Establishment of an infectious enteric disease study, 1978-1979
    49 9-10
    N01-AI-82681 - Operation of an experimental virus vaccine production laboratory, 1988-1989
    49 11
    N01-AO-52703 - Care and housing of AIDS research animals, 1997-1998
    49 12
    N01-AO-52706 - Facility for non-human primates utilized in infectious disease research, 1998
    49 13
    PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture, 1966
    49 14
    PH-43-62-80 - Production of enterovirus antisera, 1965
    49 15
    PH-43-62-127 - Preparation of immune serum to enteroviruses, 1965
    49 16
    PH-43-62-129 - Standardization of picornavirus immune sera, 1965
    49 17-26
    PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine, 1962-1970
    49 27-29
    PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance, 1966-1968
    49 30-32
    PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines, 1966-1968
    49 33
    PH-43-62-839 - Preparation of mycoplasma antigene and antisera, 1965
    49 34-35
    PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children, 1968, 1970
    49 36-38
    PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population, 1966-1968
    50 1-4
    PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species, 1964-1966
    50 5-6
    PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses, 1965, 1967
    50 7
    PH-43-63-81 - Development, growth and characterization of virus induced tumor cells, 1967
    50 8
    PH-43-63-90 - Upper respiratory virus, 1965
    50 9
    PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory, 1966
    50 10-11
    PH-43-63-562 - Prevention of viral respiratory infections, 1964, 1968
    50 12
    PH-43-63-563 - Vaccine studies in a children's center, 1968
    50 13
    PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection, 1967
    50 14-16
    PH-43-63-582 - Respiratory disease vaccine, 1962-1967
    50 17-18
    PH-43-63-1128 - Surveillance of respiratory infections in an industrial population, 1966, 1968
    50 19-20
    PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population, 1967-1968
    50 21
    PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus, 1964
    50 22
    PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses, 1965
    50 23
    PH-43-63-1177 - Reference seeds for echo and coxsackieviruses, 1965
    50 24
    PH-43-64-529 - Preparation and development of viral reagents, 1965
    50 25-27
    PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis, 1966, 1968, 1972
    50 28-29
    PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine, 1966-1967
    50 30-32
    PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs, 1965-1967
    50 33-34
    PH-43-65-562 - Rhinovirus reference laboratory, 1966-1967
    50 35-36
    PH-43-65-563 - Studies of RSV vaccines, 1966-1967
    50 37
    PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents, 1968
    50 38-40
    PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections, 1966-1968
    50 41
    PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers, 1966
    50 42-43
    PH-43-66-93 - Rubella vaccine development, 1967-1968
    50 44
    PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines, 1967
    50 45
    PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines, 1968
    50 46-47
    PH-43-66-461 - Research and development of an inactivated rubella virus vaccine, 1967-1968
    50 48
    PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents, 1966
    50 49
    PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man, 1966-1968
    50 50
    PH-43-66-565 - Development of a live vaccine for human influenza, 1966
    50 51-52
    PH-43-66-917 - The role of infection in precipitating sudden deaths in infants, 1969
    50 53-54
    PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions, 1967-1968
    50 55
    PH-43-66-970 - Operation of a tissue culture developmental laboratory, 1967
    50 56
    PH-43-66-971 - Provide for the operation of a serology laboratory, 1967
    50 57-58
    PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children, 1968, 1970
    50 59-60
    PH-43-67-75 - The testing of rubella virus vaccines in human volunteers, 1967-1968
    50 61
    PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus, 1968
    50 62
    PH-43-67-77 - Biologic and antigenic studies with rubella virus, 1968
    50 63
    PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines, 1968
    50 64-65
    PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines, 1967
    50 66
    PH-43-67-80 - Studies of rubella vaccine efficacy, 1967
    50 67
    PH-43-67-91 - Research and development of respiratory disease vaccines, 1967-1968
    50 68
    PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines, 1973
    50 69
    PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis, 1969
    50 70-71
    PH-43-67-745 - Studies of local antibody in respiratory viral immunity, 1967, 1969
    50 72
    PH-43-68-81 - Operation of a rubella virus service laboratory, 1968
    50 73
    PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein, 1968
    50 74
    PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines, 1968
    51 1-4
    PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses, 1968-1975
    51 5-6
    PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1968-1969
    51 7
    Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus, 1977
    51 8
    Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus, 1978-1981
     
    Cooperative Research and Development Agreements (CRADA), 1972-2003 [subseries]:
    51 9
    License agreements, 1988-1996
    51 10-11
    Chiron, 1988-2003
    51 12-15
    Intracel, 1995-1997
    51 16-21
    Lederle, 1992-2000
    52 1-10
    Lederle (cont'd), 1992-2000
    52 11
    MedImmune, 2002
    52 12
    Praxis, 1987-1988
    52 13
    Upjohn, 1988
    52 14-27
    Wyeth, 1972-2001
    53 1-5
    Wyeth (cont'd), 1972-2001
     
    Series 4: Patents, 1966-2008 [series]:
    53 6-7
    Chanock's patents, 1967-2000
    53 8-10
    Patent status reports, 2002-2008
    53 11
    Confluent growth of mycoplasma - application, 1966-1967
    53 12-15
    #3,317,393 - Immunization by selective infection of the intestinal tract with an encapsulated live virus, 1967-2005
    53 16-17
    #3,992,522 - Temperature sensitive recombinant mutant viruses and a process for producing same, 1974-1976
    53 18
    #4,552,757 - Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus, 1984-1988
    53 19-20
    #4,571,385 - Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors, 1995-1999
    53 21-29
    #4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth), 1998-2005
    54 1-4
    #4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth) (cont'd), 1998-2005
    54 5
    #4,751,080 - Vaccine against rotavirus diseases, 1988
    54 6-9
    #4,800,078 - Immunotherapeutic method of treating respiratory disease by intranasal administration of IGB, 1966-1993
    54 10
    #5,646,033 - African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines, 1997
    54 11-18
    #5,762,905 - Human neutralizing monoclonal antibodies to respiratory syncytial virus, 1995-2004
    54 19
    #5,882,651 - Attenuated respiratory syncytial virus vaccine compositions, 1993
    54 20
    #5,911,998 - Method of producing a virus vaccine from an African green monkey kidney cell line, 1999
    54 21
    #5,922,326 - Attenuated respiratory snycytial virus vaccine compositions, 1993
    54 22
    #6,117,667 - Method for producing an adapted virus population from an African green monkey kidney cell line, 2000
    54 23-33
    #6,184,024 - Chimeric and/or growth restricted flaviviruses, 1992-2007
    55 1-2
    #6,184,024 - Chimeric and/or growth restricted flaviviruses (cont'd), 1992-2007
    55 3-9
    #6,497,884 - Chimeric vaccine against tick-borne encephalitis virus, 2000-2007
    55 10
    #6,660,273 - Chimeric vaccine against tick-borne encephalitis virus, 2003
    55 11-12
    #6,676,936 - Chimeric and/or growth-restricted flaviviruses, 1998-1999
    55 13-19
    #6,794,174 - Full-length infectious cDNA clones of tick-borne flavivirus, 2001-2008
    55 20
    #7,150,984 - Attenuated human rotavirus vaccine, 2006
    55 21
    #7,364,737 - Human neutralizing monoclonal antibodies to respiratory syncytial virus, 2008
    55 22-25
    #7,932,074 - Multivalent human-bovine rotavirus vaccine, 1998-2006
    55 26-28
    #8,778,671 - Construction of West Nile virus and dengue fever chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus, 2001-2004
     
    Series 5: Writings/Reprints, 1953-2007 [series]:
    55 29
    Chanock numbered bibliography (1-653), 2003
     
    Numbered Articles by Dr. Chanock, 1953-2003 [subseries]:
    55 30-34
    1-5, 1953-1954
    56 1-144
    6-151 [incomplete], 1954-1967

    [missing 127, 149]

    57 1-148
    152-323 [incomplete], 1967-1976

    [missing 169, 194, 200, 203, 209, 219, 221, 230, 236, 247, 250, 252-253, 257, 259, 290, 291, 293-295, 301, 310, 315, 319]

    58 1-194
    325-568 [incomplete], 1976-1989

    [missing 330, 340, 342, 348, 350, 364, 370, 384, 396, 411, 443-444, 449-450, 460, 464-465, 467, 470, 471, 474-477, 479, 481-482, 502-503, 505, 509, 524-525, 527, 532, 534, 537, 540-542, 546, 551-552, 557-558, 560, 563-566]

    59 1-46
    570-653 [incomplete], 1989-2003

    [missing 574, 576, 579-581, 584, 586, 589-594, 597-600, 602, 605, 608, 611-612, 615, 618, 620-623, 625, 629-630, 641-644, 647-649]

     
    Unnumbered Reprints by Dr. Chanock, 1954-2005 [subseries]:
    59 47
    Respiratory syncytial vaccine - with Murphy, Collins, and Olmsted, undated
    59 48
    Recovery and characterization of hemagglutinins from two immunologically distinct types of dengue virus - with Sabin and Sweet, c.1954
    59 49
    III. Production of illness and clinical observations in adult volunteers, 1961
    59 50
    Primary atypical pneumonia, 1966
    59 51
    Genetic approaches to the prevention of influenza A virus infection - with Murphy, 1981
    59 52
    Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus - with Hendry, Burns, Walsh, Graham, Wright, Hemming, Rodriguez, Kim, Prince, McIntosh, and Murphy, 1988
    59 53
    Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides - with Markoff, Bray, Lai, Eckels, Summers, Gentry, Houghten, and Lerner, 1988
    59 54
    Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev, 2005
     
    Drafts by Dr. Chanock, c.1960s-c.2007 [subseries]:
    59 55
    Untitled fragments, undated
    59 56
    Acute respiratory disease of infancy and childhood - present understanding and prospects for prevention, undated
    59 57
    Blueprint for use of live virus vaccine to prevent a pandemic of influenza A virus - with Murphy and Spring, undated
    59 58
    Decreased virulence and protective effect of a genetically stable temperature-sensitive mutant of m. pneumoniae in human volunteers, undated
    59 59
    Infection of immature white mice by the addition of western equine encephalitis virus to the feed, undated
    59 60
    Parainfluenza, respiratory syncytial, and New Castle disease viruses - with Parrott (title page only), undated
    59 61
    Development of immunity - outline, c.1960s
    59 62
    Prospects for control of auto viral mycoplasmal respiratory tract disease by vaccination, c.1960s
    59 63
    Untitled draft re pediatric respiratory illnesses at Camp Lejeune 1959-1963, c.1964
    59 64
    The contribution of adenoviruses to respiratory tract illness among children, c.1965
    59 65
    The relationship of mycoplasma pneumoniae to pediatric respiratory tract disease - with Canchola, Brandt, Kim, and Parrott, 1970
    59 66
    Guide for the collection and transport of virological specimens, 1975
    59 67
    Virus and mycoplasma pneumoniae in respiratory disease patients, January 1975-June 1976 - with Brandt, Kim, Arrobio, and Parrott, c.1977
    59 68
    Isolation and characterization of temperature-sensitive mutants of influenza A virus, 1977
    59 69
    Bovine respiratory syncytial virus: studies in experimental animals - with Prince, Suffin, Horswood, Camargo, Prevar, and Sly, 1980
    59 70
    Respiratory syncytial virus in cotton rats: growth, antigenicity and protective efficacy of two temperature-sensitive, live virus vaccine candidates, ts-1-NG-1 and ts-1-NG-16 - with Prince, Horswood, Prevar, Camargo, Suffin, and Spring, 1980
    59 71
    HLA antigens in severe respiratory syncytial virus disease in infants and early childhood - with Johnson, Kiim, Hartzman, Parrott, Woody, and Sell, 1981
    59 72
    Studies of avian-human reassortant influenza A viruses in seronegative (HAE<1:8) adult volunteers, 1984-86 - with Clements, Murphy, Snyder, Buckler-White, Tierney, Betts, Dolin, Black, and Sears, 1986
    59 73
    Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations, 1991
    59 74
    A live cold-passaged temperature-sensitive mutant of human respiratory syncytial virus is highly attenuated, genetically stable, immunogenic, and efficacious against wild type challenge in seronegative chimpanzees, 1993
    59 75
    "Cold-passaged and temperature sensitive (ts) derivatives of the partially attenuated respiratory syncytial virus ts-4 mutant are more restricted in replication in mice - with Crowe, Jr., Hsu, Lubeck, and Murphy, c.1994
    59 76
    Short summary of studies of chimeric viruses as candidates for live attenuated vaccine against tick-borne encephalitis, 2000-2005
    59 77
    Comparison of live and inactivated tick-borne encephalitis virus vaccines for immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev, 2005
    59 78
    Early experiences with influenza adjuvated vaccines, c.2007
     
    Untitled Drafts by Dr. Chanock, c.1955-c.2007 [subseries]:
    59 79
    Miscellaneous individual pages, undated
    59 80
    The interplay of immunologic factors in acute viral respiratory tract disease, undated
    59 81
    pages 16-22 re ts mutants, undated
    59 82
    There is compelling evidence that local immunity plays a major role in resistance to most respiratory viral pathogens, undated
    59 83
    re temperature-sensitive mutants, undated
    59 84
    re vaccines against RSV, undated
    59 85
    re arthropod-borne encephalitis viruses, c.1955
    59 86
    pages 3-15 re RS virus, c.1962
    59 87
    report on tests of inactivated respiratory virus vaccines, c.1967-1968
    59 88
    mycoplasma pneumoniae, 1973
    59 89
    RS virus (RSV) is the major viral pathogen of the respiratory tract, 1975
    59 90
    Respiratory syncytial (RS) virus is the major etiologic agent of bronchiolitis, 1976
    59 91
    pages 25-90 of "f-rot.doc", 1989
    59 92
    Evaluation of antibody response to RSV, 1990
    59 93
    pages 9-29 re serum RSV antibodies, c.1994
    59 94
    re vaccine against TBEV, c.2002
    59 95
    re Langat virus (LGT) - with Kyle, 2002
    59 96
    re flaviviridae tick-borne encephalitis viruses (TBEV), 2004
    59 97
    re protective immune response against 1918 influenza virus, c.2007
     
    Books Inscribed to Dr. Chanock, 1998-2004 [subseries]:
    60 1
    Textbook of Military Medicine - Part I Warfare, Weaponry and the Casualty, 1998
    60 2
    Hantavirus hunting - by Ho-Wang Lee, 2004
     
    Series 6: Meetings, 1954-2005 [series]:
    60 3
    Proceedings of the Conference on Complement Fixation, 5 August 1954
    60 4-5
    Proceedings of the Conference on Neutralization, 18-20 May 1955
    60 6
    Proceedings of the Round Table Conference on Genetic Aspects of Virus-Host Cell Relationships with Particular Reference to Polioviruses, 23-24 February 1956
    60 7
    Society for Pediatric Research annual meeting, 8-9 May 1959
    60 8
    Meetings - general, 1960
    60 9
    Meetings - general, 1961
    60 10-11
    Russian trip, May 1961
    60 12
    Meeting in Prague, Czechoslovakia, 23-27 May 1961
    60 13
    World Health Organization, Geneva, 15-21 August 1961
    60 14
    Meetings - general, 1962
    60 15
    International Postgraduate Course Respiratory Virus Diseases, 11-14 April 1962
    60 16
    Newer Respiratory Disease Viruses, 3 October 1962
    60 17
    Meetings - general, 1963
    60 18
    World Health Organization Respiratory Virus meeting, 1-6 July 1963
    60 19
    University of Wisconsin Symposium on New Castle Disease, 15 July 1963
    60 20
    7th International Congress on Tropical Medicine, 1-11 September 1963
    60 21
    Seminar on Respiratory Disease, 9 October 1963
    60 22
    Meetings - general, 1964
    60 23
    American College of Physicians, 6-10 April 1964
    60 24
    World Health Organization directors, 20-27 July 1964
    60 25
    Meetings - general, 1965
    60 26
    Rhinovirus workshop, 25 January 1965
    60 27
    American Society of Clinical Investigation, 3 May 1965
    60 28
    World Health Organization, 27 September 1965
    60 29
    Armed Forces Epidemiological Board Commission on Viral Infections, 14-15 October 1965
    60 30
    International Congress of Pediatrics, 7 November 1965
    60 31
    Conference on Acute Infectioius Respiratory Diseases, 14-15 December 1965
    60 32
    Meetings - general, 1966
    60 33
    Mycoplasma conference, 9-11 February 1966
    60 34
    American Society for Clinical Investigation, 1 May 1966
    60 35
    New York Academy of Science, 11 May 1966
    60 36
    Conference on Live Oral Adenovirus Vaccine in Marine and Navy Recruits, 10-11 June 1966
    61 1
    Pan American Health Organization, 7 November 1966
    61 2
    Meetings - general, 1967
    61 3-4
    Human Vaccines - Possible Oncogenic Implications, 9 January 1967
    61 5
    Laboratory Methods in the Isolation and Identification of Respiroviruses and Enteroviruses, 3-4 July 1967
    61 6
    Respiratory Syncytial Virus Workshop, 10 July 1967
    61 7
    Conference on Measles Virus, etc., 13 September 1967
    61 8
    Scientific Group on Respiratory Viruses, 9-14 October 1967
    61 9
    American Academy of Pediatrics, 25 October 1967
    61 10
    Symposium honoring Dr. M. D. Eaton, 1 December 1966
    61 11
    Meetings - general, 1968
    61 12
    Clinical at the College of Physicians and Surgeons, Columbia, University, 27 January 1968
    61 13-14
    Gustav Stern Symposium on Perspectives in Virology, 29 January 1968
    61 15
    American Academy of Allergy, 5-7 February 1968
    61 16
    American Epidemiological Society, 29-30 March 1968
    61 17
    American Medical Association, 23-24 April 1968
    61 18
    American Society for Clinical Investigation, 5 May 1968
    61 19
    Society for Epidemiological Research, 10-11 May 1968
    61 20
    Postgraduate Workshop, University of Maryland, 2 June 1968
    61 21
    Third International Symposium on Aerobiology, 15-19 September 1968
    61 22
    Influenza Genetics, 11-12 November 1968
    61 23
    Armed Forces Epidemiological Board Committee on Influenza, 18-20 November 1968
    61 24
    Twelfth International Congress of Pediatrics, 1-7 December 1968
    61 25
    Meetings - general, 1969
    61 26
    Vaccine Development Committee meeting, 27-28 January 1969
    61 27
    International Conference on Rubella Immunizations, 18-20 February 1969
    61 28
    Conference on Immunology, 2 April 1969
    61 29-30
    World Health Organization Virus Reference Centres meeting, 22-25 April 1969
    61 31
    American Society for Microbiology, 4-9 May 1969
    61 32
    American Society for Clinical Investigation, 5 May 1969
    61 33
    American Thoracic Society, 24-26 May 1969
    61 34
    Gustav Stern meeting, 25-26 May 1969
    61 35
    Ad hoc Conference on Australia Antigen and Hepatitis, 23-24 June 1969
    61 36
    Vaccine Development Workshop on Vaccine Testings, 27 June 1969
    61 37
    Virus Diseases of the Respiratory Tract, 23 September 1969
    61 38
    International Working Conference on Influenza, 14-16 October 1969
    61 39
    Infectious Disease Society of America, 25-26 October 1969
    61 40
    International Conference on Vaccines against Viral and Rickettsial Diseases of Man, 7-11 November 1969
    61 41
    Committee on Influenza, 17-19 November 1969
    61 42
    NICHD Immunology Workshop, 11-13 December 1969
    61 43
    Secretory Antibody, 10-13 December 1969
    61 44
    Human Responses to Viral Antigens, 3 August 1971
    61 45
    Mycoplasma and Mycoplasma-like Agents of Animal and Plant Diseases, 8-10 January 1973
    61 46
    Influenza Workshop IV, 24 January 1973
    61 47
    Acute Respiratory Diseases, 8-9 March 1973
    61 48
    Influenza Vaccines, University of Maryland, 13 March 1973
    61 49
    Fogarty Center Conferences on Preventive Medicine, 15-16 March 1973
    61 50
    ICN/UCLA Symposium on Molecular Biology-Virus Research, 18-23 March 1973
    61 51
    New Approaches for Inducing Natural Immunity to Pyogenic Organisms, 20-23 March 1973
    61 52
    Influenza Workshop V on Influenza Vaccines, 3-4, 14 April 1973
    62 1
    Influenza Workshop V on Influenza Vaccines (cont'd), 3-4, 14 April 1973
    62 2
    American Epidemiological Society, 6-7 April 1973
    62 3
    Epidemic Intelligence Service Conference, 9-13 April 1973
    62 4-5
    Directors of World Health Organization Reference Centers, 16-19 April 1973
    62 6
    U.S.-Japan Program, 23-27 July 1973
    62 7-8
    Problems of Bacteriophage Contamination, 1 August 1973
    62 9
    FIC Subcommittee on Infectious Diseases, 14-16 September 1973
    62 10
    Infectious Diseases Society of America, 17-18 September 1973
    62 11
    Parainfluenza and RS Candidate Vaccines, 5 October 1973
    62 12
    Animal Influenza and its Significance for Human Infections, 11-12 October 1973
    62 13
    University of Chicago Alumni Banquet, 23 October 1973
    62 14
    National Academy of Sciences, 23 October 1973
    62 15
    Interagency Meeting on Influenza, 19 November 1973
    62 16-17
    World Health Organization, 1-5 September 1975
    62 18
    Joint Working Conference of the Virus Cancer Program, 3-5 November 1975
    62 19
    Influenza meeting, NIH, 12 January 1976
    62 20
    Influenza Program Review meeting, NIH, 15-16 January 1976
    62 21
    Working Group on Pandemic Influenza, 26-28 January 1976
    62 22
    Bacterial and Viral Gastroenteritis, 5-6 February 1976
    62 23
    Bureau of Biologics, 20 February 1976
    62 24
    Walter Reed Ad Hoc meeting, 8 March 1976
    62 25
    Armed Forces Epidemiological Board, 12 March 1976
    62 26
    Bureau of Biologics, 25 March 1976
    62 27
    Current Status and Prospect for Improved and New Bacterial Vaccines, 29 March-1 April 1976
    62 28
    Influenza meeting, NIH, 15 April 1976
    62 29
    National Academy of Sciences, 26-28 April 1976
    62 30
    American Epidemiological Society, 29 April-1 May 1976
    62 31
    Association of American Physicians, 30 April-2 May 1976
    62 32
    American Society for Microbiology, 2-7 May 1976
    62 33
    Association of American Physicians, 4 May 1976
    62 34
    Conference on Persistent Viral Infections, 13-16 June 1976
    62 35
    Bureau of Biologics, 21-22 June 1976
    62 36
    Bronchiolitis workshop, 28-29 June 1976
    62 37
    Festschrift for Albert Sabin, 26 August 1976
    62 38
    Consensus Development on Use of Amantadine, 15-16 October 1976
    62 39
    Infectious Disease Society of America, 25-26 October 1976
    62 40
    Ad Hoc Viral and Rickettsial Disease Study Group, 8 November 1976
    62 41
    Viral and Bacterial Vaccines, Present Knowledge and Future Development International Symposium, 7-8 September 1977
    62 42
    Chinese delegation, 1979
    62 43
    Experimental Herpesvirus Vaccine workshop, 7-9 February 1979
    62 44
    Surgeon General's Meeting on Influenza, 12 February 1979
    62 45
    Medical Research Council, 20 February 1979
    62 46
    Symposium on Potentiation of Immune Response to Vaccines, 20-21 February 1979
    62 47
    The Royal Society Meeting on Influenza, 21-22 February 1979
    63 1
    Secretary's Conference on Influenza, 6 March 1979
    63 2
    Attenuated Influenza Vaccine workshop, NIH, 9 March 1979
    63 3
    American Physicians Fellowship Program, NIH, 29-30 March 1979
    63 4
    American Epidemiological Society, 30-31 March 1979
    63 5
    Vaccine Studies in the Elderly, 30 April 1979
    63 6
    American Society for Microbiology, 4-11 May 1979
    63 7
    Influenza B Viruses workshop, 30-31, 1979
    63 8
    Prevention of Major Infectious Diseases: Current Concerns and Future Promise, 20-21 September 1979
    63 9
    Medical Society of the District of Columbia, 27-28 September 1979
    63 10
    Infectious Diseases Society of America, 5-6 October 1979
    63 11
    Molecular Approaches to Vaccine Development, 10 October 1979
    63 12
    U.S.-U.S.S.R. Influenza meeting, 16-18 October 1979
    63 13
    Genetic Variation of Viruses, 28-30 November 1979
    63 14
    Australian Commonwealth Scientific and Industrial Research Organization, 10-12 December 1979
    63 15
    Perspectives in Virology, 4-5 February 1980
    63 16
    Australian Academy of Science, 8-12 February 1982
    63 17
    Duke University seminar, 4 February 1980
    63 18
    Attenuated Vaccines, 10 March 1980
    63 19
    Pritzker School of Medicine Council meeting, 2 May 1980
    63 20
    American Society for Microbiology, 11-16 May 1980
    63 21
    Eradication of Infectious Diseases, 27-28 May 1980
    63 22
    Infectious Disease Society of America, 25-26 September 1980
    63 23
    Negative Strand Viruses, 27 October-1 November 1980
    63 24
    World Health Organization Consultation on Influenza, 5-6 November 1980
    63 25
    Department of Microbiology and Molecular Genetics seminar, 2 December 1980
    63 26
    ICN/UCLA Symposium on Genetic Variation of Influenza Viruses, 8-13 March 1981
    63 27
    International Symposium on Viral Hepatitis, 30 March-2 April 1981
    63 28
    Department of Microbiology and Immunology seminar, Duke University, 16 April 1981
    63 29
    Mt. Sinai Symposium on Infections Caused by Enteric Viruses, 4 June 1981
    63 30
    International Congress of Virology, 2-7 August 1981
    63 31
    Respiratory Diseases meeting, 16 October 1981
    63 32
    Workshop on Respiratory Diseases, 21-22 June 1982
    63 33
    International Symposium on Polilomyelitis Control, 14-17 March 1983
    63 34
    NIAID Workshop on AIDS, 5-6 April 1983
    63 35
    Towards New Vaccines Against Virus Infections, 21-23 June 1983
    63 36
    London Conference on Influenza, 21-23 September 1983
    63 37
    Association of American Physicians, 29 April-2 May 1983
    63 38-47
    Modern Approaches to Vaccine, 31 August-4 September 1983
    63 48
    Negative Strand Virus meeting, 11-17 September 1983
    63 49
    International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections, 9-12 October 1983
    63 50
    19th Immunization Conference - proceedings, 21-24 May 1984
    63 51
    International Congress of Virology, 1-7 September 1984
    63 52
    International Workshop on the Molecular Biology of Flaviviruses, 29 November-1 December 1984
    63 53
    Status of Attenuated Influenza Vaccines, 10-11 December 1984
    63 54
    Rowe Symposium, 11-12 February 1985
    63 55
    Rotavirus Vaccine Work Group, 13 March 1985
    63 56
    Genetically Altered Viruses, 28 April-1 May 1985
    64 1
    American Society for Virology, 21-25 July 1985
    64 2
    World Health Organization Steering Committee on Acute Respiratory Viruses, 29-30 July 1985
    64 3-5
    Modern Approaches to Vaccines, 11-15 September 1985
    64 6
    The Biology of Negative Strand Viruses, 15-20 September 1985
    64 7
    Expression of Foreign Genes, 4-7 October 1985
    64 8
    RSV Symposium, 16 October 1985
    64 9
    Duke University Academic Visiting Professor, 16-18 December 1985
    64 10
    Scripps Scientific Review Committee, 13-15 January 1986
    64 11
    Rowe Symposium, 3-4 February 1986
    64 12
    Vaccinia-Vectoring, 31 March 1986
    64 13
    Cosmos Club award, Albert Sabin, 15 April 1986
    64 14
    Vaccine Supply and Innovation workshop, 24-25 April 1986
    64 15
    Association of American Physicians, 2-4 Mary 1986
    64 16
    Influenza Viruses, 20 May 1986
    64 17
    World Health Organization Acute Respiratory Viruses meeting, 27-28 June 1986
    64 18
    FEBS meeting, 24-29 August 1986
    64 19
    Infectious Diseases Society of America, 2-3 October 1986
    64 20
    Scripps Scientific Review Committee, 10 January 1987
    64 21
    Rowe Symposium, 2-3 February 1987
    64 22
    AIDS Vaccines workshop, 25-27 March 1987
    64 23
    Workshop on Respiratory Syncytial and Parainfluenza Viruses, 4-5 May 1987
    64 24
    Scholars-in-Residence symposium, 11-14 May 1987
    64 25
    Pasteur Centenary Symposium, 26-28 May 1987
    64 26
    American Society for Virology, 31 May-4 June 1987
    64 27
    International Conference on AIDS, 1-5 June 1987
    64 28-29
    Nobel Symposium on the Vaccines of the Future, 23-26 August 1987
    64 30
    International Symposium on Infectious Diseases, 11-12 November 1987
    64 31
    Live Viral Vaccines for Respiratory and Enteric Tract Diseases, 24 November 1987
    64 32
    Conference on the Development of Vaccines Against HIV and AIDS, 14-15 December 1987
    64 33
    Scripps Scientific Review Committee, 14 January 1988
    64 34
    Conference on Poliomyelitis Vaccines: Re-evaluating Policy Options, 21-22 January 1988
    64 35
    Rowe Symposium, 1-2 February 1988
    64 36
    National Academy of Sciences Committee on International Security and Arms Control, 16 March 1988
    64 37
    Oral Immunization symposium, 21-22 March 1988
    64 38
    NIH Seminar, 6 April 1988
    64 39
    American Pediatric Society Centennial Celebration, 3 May 1988
    64 40
    National Academy of Sciences and Academy of Sciences of the USSR on Biological Weapons, 9-11 May 1988
    64 41
    Wagner Symposium, 15-16 May 1988
    64 42
    Live Attenuated Influenza Virus Vaccine, 26 May 1988
    64 43
    American Society for Virology, 12-16 June 1988
    64 44
    NIH Rotavirus Vaccine workshop, 8-9 September 1988
    64 45
    Modern Approaches to New Vaccines Including Prevention of AIDS, 14-18 September 1988
    64 46
    Immunology of Virus Diseases, 26-28 October 1988
    64 47
    Genetic Basis of Human Disease, 30 November-1 December 1988
    64 48
    Institute of Medicine Research Briefing Panel, 27-28 April 1989
    64 49
    Symposium on Respiratory Virus Vaccine Development, 1 May 1989
    64 50
    American Society for Virology, 9-13 July 1989
    64 51-52
    Modern Approaches to New Vaccines Including Prevention of AIDS, 20-24 September 1989
    64 53
    International Conference on Comparative and Applied Virology, 15-21 October 1989
    64 54
    Rowe Symposium, 5-6 February 1989
    64 55-56
    American Thoracic Society, 23 May 1990
    65 1
    American Thoracic Society (cont'd), 23 May 1990
    65 2
    International Congress of Virology, 26-31 August 1990
    65 3
    Children's Vaccine Initiative, 6 August 1990
    65 4
    Colloquium on Human Diseases - Molecular Mechanisms of Viral Pathogenesis, 19-20 October 1990
    65 5
    Animal Models of Respiratory Syncytial Virus Infections, 24-25 October 1990
    65 6
    NIH Rotavirus Vaccine Workshop, 5-6 November 1990
    65 7
    Rowe Symposium, 4-5 February 1991
    65 8
    Saul Krugman Festschrift, 12 April 1991
    65 9
    Inauguration of Richard M. Haidack Distinguished Professorship in Medicine, 29 May 1991
    65 10
    Pathogenesis Symposium, 5 December 1991
    65 11
    Rowe Symposium, 3-4 February 1992
    65 12
    NIAID Interdivisional AIDS Working Group, 24 April 1992
    65 13
    Measles workshop, 14-15 September 1992
    65 14
    Lounsbury Award Jury Dinner, 5 November 1992
    65 15
    Innovations in Therapy of Human Viral Diseases, 6-7 December 1992
    65 16
    Molecular Pathogenesis of Infections and Tumors, 5-6 May 1994
    65 17
    Scientific Symposium to Honor the Work of Janet W. Hartley, 13 September 1994
    65 18
    Scientific Meeting of the Australian Society for Microbiology, 26-30 September 1994
    65 19
    Molecular Approaches to the Control of Infectious Diseases, 5-9 October 1994
    65 20-21
    Frank and Bobbie Fenner Conference in Medical Research, 28-30 November 1994
    65 22
    Office of Science and Technology Policy meeting, 29 March 1995
    65 23
    Fogarty Advisory Board, 23 May 1995
    65 24
    Igor Tamm Memorial Symposium, 30 November 1995
    65 25
    Thomas Merigan Lecture, 23-29 May 1996
    65 26
    Conference on Immunoglobulins, 2-4 June 1996
    65 27
    Antibody workshop, 2-4 June 1996
    65 28
    Simian Virus 40 workshop, 27-28 January 1997
    65 29-30
    NIAID Principal Investigators' retreat, 20-21 November 1997
    65 31
    Center for Biologics Evaluation and Research, Vaccines and Related Biological Products Advisory Committee, 19-20 Novebmer 1998
    65 32
    American Epidemiological Society, 18-19 March 1999
    65 33
    Memorial Symposium for Robert Huebner, 11 November 1999
    65 34
    Conference on Vaccine Research, 1-2 May 2000
    65 35
    NIAID Principal Investigators' workshop, 6-7 November 2000
    65 36
    NIAID Principal Investigators' workshop, 14-15 November 2002
    65 37
    RSV 2003 Symposium, 8-11 November 2003
    65 38
    Trans-NIH/FDA Intramural Biodefense Symposium, 7-8 April 2004
    65 39
    Rotavirus Symposium, 7-9 July 2005
    65 40
    RSV Symposium, 15-18 September 2005
     
    Series 7: Lectures and Speeches, 1951-2005 [series]:
    65 41
    Control of pediatric viral diseases: past successes and future prospects, undated
    65 42
    Untitled ["There seems little reason to doubt that antibody in serum is an important mediator"], c.1950s
    65 43
    Hemagluttination with the virus of western equine encephalitis - with Sabin, 30 November 1951
    65 44
    Hemagglutinins of St. Louis and western equine viruses - isolation, properties, and use for diagnosis and epidemiologic survey, 5 May 1952
    65 45
    The Hemagglutination test for Japanese encephalitis, a diagnosis and survey tool, 1955
    65 46
    Untitled ["I'd like to start off by describing in some detail, of course I'll probably be offending some, viruses and some of the tests we use in"], 25 November 1958
    65 47
    Mycoplasma pneumoniae infections - prospects for live and inactivated vaccines, c.1963
    65 48
    Infections caused by mycoplasmas, 4 November 1965
    65 49
    Australia antigen and serum hepatitis, 1970
    65 50
    Untitled [at International Congress of Microbiology], August 1970
    65 51
    Parainfluenza virus epidemiology, 3 May 1974
    65 52
    Untitled ["For approximately the past five years the Laboratory of Infectious Diseases at the NIH in Bethesda has been involved in the study of acute infectious nonbacterial gastroenteritis."], September 1975
    65 53
    Untitled ["This morning I would like to discuss two areas of study in which we have been involved concerning human reovirus-like agent of infantile gastroenteritis.", 1976
    65 54
    Chicago talk, 1977
    65 55
    R. E. Dyer lecture, 30 May 1978
    65 56
    Medicine for Laymen series lecture, 4 December 1979
    65 57
    Smadel lecture at Infectious Diseases Society meeting, 26 September 1980
    65 58
    Saz Immunology Lecture, 9 October 1985
    65 59
    Successful strategy for selection and characterization of live poliomyelitis virus vaccine strains, 27 October 1986
    66 1
    Feldman Memorial Lecture, 17-18 March 1987
    66 2
    FAES lecture, 7 December 1988
    66 3-4
    Talamo lecture, 4 April 1990
    66 5
    Children's Hospital National Medical Center, 22 October 1990
    66 6
    Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations, 7 February 1991
    66 7
    Careers in virology: a good beginning is usually required for a good ending, 7 or 12 February 1991
    66 8
    Albert Sabin eulogy, 1993
    66 9
    Natural history of RSV, 1994
    66 10-11
    Sabin Lecture, Cold Spring Harbor, September 1995
    66 12
    Untitled ["sabin.doc"], 1997
    66 13
    Huebner Symposium lecture, 10 November 1999
    66 14
    Speech in honor of Brian Murphy, 2003
    66 15
    R. Walter Schlesinger, M.D. (1913-2003), 5 November 2003
    66 16
    Tribute to Albertk Kapikian, honored with Albert Sabin Foundation Gold Medal, 16 May 2005
     
    Series 8: Videocassettes, 1985-1987 [series]:
    67
    Wallace P. Rowe Symposium [11 Umatic videocassettes], 12 February 1985
    68
    A Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday [9 Umatic, 5 vhs videocassettes], 26 August 1986
    68
    Bldg10/ACRF [1 Umatic videocassette], 11 May 1987